10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________

FORM 10-Q

_______________________________

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2016

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission File Number: 001-15401

____________________________________________________________________________________________________________

EDGEWELL PERSONAL CARE COMPANY

(Exact name of registrant as specified in its charter)

Missouri	43-1863181
(State or other jurisdiction of incorporation or organization)	(I. R. S. Employer Identification No.)
1350 Timberlake Manor Parkway
Chesterfield, Missouri	63017
(Address of principal executive offices)	(Zip Code)
(314) 594-1900
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer", "accelerated filer", and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x		Accelerated filer	o
Non-accelerated filer	o	(Do not check if smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No x

Indicate number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

Common shares, $0.01 par value - 57,419,038 shares as of January 31, 2017.

1

EDGEWELL PERSONAL CARE COMPANY

INDEX TO FORM 10-Q

PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited).
	Condensed Consolidated Statements of Earnings and Comprehensive Income for the three months ended December 31, 2016 and 2015.	3
	Condensed Consolidated Balance Sheets as of December 31, 2016 and September 30, 2016.	4
	Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2016 and 2015.	5
	Notes to Condensed Consolidated Financial Statements.	6
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations.	27
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	38
Item 4.	Controls and Procedures.	38
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings.	39
Item 1A.	Risk Factors.	39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	39
Item 3.	Defaults Upon Senior Securities.	39
Item 4.	Mine Safety Disclosures.	39
Item 5.	Other Information.	39
Item 6.	Exhibits.	40
SIGNATURES		41

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

(unaudited, in millions, except per share data)  

	Three Months Ended December 31,
	2016			2015
Net sales	$	485.0		$	495.1
Cost of products sold	257.0			267.6
Gross profit	228.0			227.5
Selling, general and administrative expense	93.8			100.4
Advertising and sales promotion expense	50.6			46.6
Research and development expense	16.3			16.0
Restructuring charges	6.9			18.5
Interest expense associated with debt	17.4			17.7
Other income, net	(1.9		)	(2.4		)
Earnings before income taxes	44.9			30.7
Income tax provision	11.4			7.0
Net earnings	$	33.5		$	23.7
Earnings per share:
Basic net earnings per share	$	0.58		$	0.40
Diluted net earnings per share	0.58			0.39
Statement of Comprehensive Income:
Net earnings	$	33.5		$	23.7
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	(38.7		)	(10.5		)
Pension and postretirement activity, net of tax of $0.6 and $0.4	3.9			0.5
Deferred gain (loss) on hedging activity, net of tax of ($4.1) and $0.9	7.9			(1.9		)
Total other comprehensive loss, net of tax	(26.9		)	(11.9		)
Total comprehensive income	$	6.6		$	11.8

See accompanying Notes to Condensed Consolidated Financial Statements.

3

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in millions, except share data)

	December 31, 2016			September 30, 2016
Assets
Current assets
Cash and cash equivalents	$	418.5		$	738.9
Trade receivables, less allowance for doubtful accounts of $5.5 and $4.9	228.4			260.7
Inventories	339.0			309.2
Other current assets	151.7			143.2
Total current assets	1,137.6			1,452.0
Property, plant and equipment, net	472.6			486.1
Goodwill	1,429.1			1,420.3
Other intangible assets, net	1,388.5			1,385.1
Other assets	27.4			28.0
Total assets	$	4,455.2		$	4,771.5
Liabilities and Shareholders' Equity
Current liabilities
Current maturities of long-term debt	$	—		$	281.8
Notes payable	18.3			18.5
Accounts payable	181.6			196.5
Other current liabilities	273.4			371.4
Total current liabilities	473.3			868.2
Long-term debt	1,680.5			1,544.2
Deferred income tax liabilities	255.8			255.3
Other liabilities	267.6			274.8
Total liabilities	2,677.2			2,942.5
Shareholders' equity
Preferred shares, $0.01 par value, 10,000,000 authorized; none issued or outstanding	—			—
Common shares, $0.01 par value, 300,000,000 authorized; 65,251,989 issued; 57,305,242 and 57,914,448 outstanding	0.7			0.7
Additional paid-in capital	1,630.1			1,642.5
Retained earnings	981.1			946.0
Common shares in treasury at cost, 7,946,747 and 7,337,541	(609.8		)	(563.0		)
Accumulated other comprehensive loss	(224.1		)	(197.2		)
Total shareholders' equity	1,778.0			1,829.0
Total liabilities and shareholders' equity	$	4,455.2		$	4,771.5

See accompanying Notes to Condensed Consolidated Financial Statements.

4

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited, in millions)

	Three Months Ended December 31,
	2016			2015
Cash Flow from Operating Activities
Net earnings	$	33.5		$	23.7
Non-cash restructuring costs	1.7			0.7
Depreciation and amortization	23.4			20.2
Non-cash items included in income, net	(0.5		)	7.2
Share-based compensation expense	5.7			6.4
Other, net	(4.1		)	(11.5		)
Changes in current assets and liabilities used in operations	(118.7		)	(105.4		)
Net cash used by operating activities	(59.0		)	(58.7		)
Cash Flow from Investing Activities
Capital expenditures	(13.7		)	(14.5		)
Acquisitions, net of cash acquired	(34.0		)	—
Net cash used by investing activities	(47.7		)	(14.5		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	146.0			347.8
Cash payments on debt with original maturities greater than 90 days	(287.0		)	(203.0		)
Net decrease in debt with original maturities of 90 days or less	(0.4		)	(2.2		)
Common shares purchased	(58.0		)	(78.9		)
Net cash (used by) from financing activities	(199.4		)	63.7
Effect of exchange rate changes on cash	(14.3		)	(8.4		)
Net decrease in cash and cash equivalents	(320.4		)	(17.9		)
Cash and cash equivalents, beginning of period	738.9			712.1
Cash and cash equivalents, end of period	$	418.5		$	694.2

See accompanying Notes to Condensed Consolidated Financial Statements.

5

EDGEWELL PERSONAL CARE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited, in millions, except per share data)

Note 1 - Background and Basis of Presentation

Background

Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell" or the "Company"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. Edgewell has a portfolio of over 25 brands and a global footprint in more than 50 countries.

The Company conducts its business in the following four segments:

• Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.

• Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves.

• Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.

• All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP"), under the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 18, 2016.

Acquisition of Bulldog Skincare. On October 31, 2016, the Company completed the acquisition of Bulldog Skincare Holdings Limited ("Bulldog"), a men's grooming and skincare products company based in the United Kingdom ("U.K."). The results of Bulldog for the post-acquisition period are included within the Company's results for the three months ended December 31, 2016. For more information on the acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements.

Statement of Cash Flows Presentation. The net presentation of borrowings and repayments under the Company's U.S. revolving credit facility in the Condensed Consolidated Statement of Cash Flows for the three months ended December 31, 2015 has been revised in order to properly reflect borrowings and repayments on a gross basis, resulting in $203.0 of repayments presented gross that were previously netted against borrowings. Net cash from financing activities reported in the Condensed Consolidated Statement of Cash Flows for the three months ended December 31, 2015 was not impacted, and the Company has concluded that the correction was not material to its financial statements and that the error was not material to any other period.

Recently Issued Accounting Pronouncements. In November 2016, the Financial Accounting Standards Board ("FASB") issued an Accounting Standards Update ("ASU") which requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. These amounts should be included within cash and cash equivalents when reconciling the beginning and ending balances for the periods shown on the statement of cash flows. The ASU requires retrospective application, and will be effective for the Company beginning October 1, 2018, with early adoption permitted. The Company does not expect to early adopt this guidance and the impact on the financial statements is not expected to be material.

6

In January 2017, FASB issued new guidance clarifying the definition of a business, reducing the number of transactions that need to be further evaluated and providing a framework to assist entities in evaluating whether both an input and a substantive process are present. The amendments in the ASU specify that when the fair value of the gross assets acquired or disposed of is concentrated in a single identifiable asset or a group of similar identifiable assets, the integrated set of assets and activities is not a business. The guidance also requires that an integrated set of assets and activities must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output to be considered a business, and removes the evaluation of whether a market participant could replace the missing elements. The ASU will be effective for transactions occurring after October 1, 2018, with early adoption permitted.

In January 2017, FASB issued new guidance which simplifies the subsequent measurement of goodwill by eliminating step 2 from the goodwill impairment test. Under existing guidance, an entity performs procedures to determine the fair value at the impairment testing date of its assets and liabilities following the same procedures required when determining the fair value of assets acquired and liabilities assumed in a business combination. The amended guidance requires an entity to perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge to the extent the carrying amount exceeds the fair value and does not exceed the total amount of goodwill allocated to the reporting unit. The ASU will be effective for the Company beginning October 1, 2021, with early adoption permitted, and should be applied prospectively. The Company is in the process of determining what impact, if any, the new guidance will have on its annual impairment testing and whether or not it will early adopt the new guidance.

Note 2 - Acquisition

Bulldog Skincare Holdings, Limited

On October 31, 2016, the Company completed the acquisition of Bulldog, a men's grooming and skincare products company based in the U.K., for £27.8, or $34.0, net of cash acquired. The acquisition creates opportunities to expand Edgewell's personal care portfolio into a growing global category where it can leverage its international geographic footprint. The acquisition was financed through available foreign cash.

The Company has recognized the assets and liabilities of Bulldog based on preliminary estimates of their acquisition date fair values. The determination of the fair values of the acquired assets and assumed liabilities, including goodwill and other intangible assets, requires significant judgment. As of December 31, 2016, this valuation analysis was not complete, including the allocations to goodwill and other intangible assets, and the related deferred tax impacts. The Company expects to complete the final fair value determinations no later than the third quarter of fiscal 2017.

As of December 31, 2016, net assets acquired totaled $35.2 and consisted of working capital and other net assets of $4.6 (including cash of $1.2), other intangible assets of $12.8 and goodwill of $17.8, representing the value of expansion into new markets and the acquired workforce of Bulldog. Goodwill is not expected to be deductible for tax purposes. The intangible assets acquired consisted primarily of the Bulldog trade name, customer relationships and product formulations. Amortization expense for the current period was estimated using a weighted-average useful life of 13.5 years for those assets preliminarily identified as definite-lived; however, the Company is still in the process of evaluating the useful lives of the acquired intangible assets. All assets are included in the Company's Sun and Skin Care segment.

Acquisition and integration costs related to the acquisition were not material.

Note 3 - Restructuring Charges

Spin Restructuring

The Company initiated certain restructuring activities related to the July 1, 2015 separation of its Household Products business into a separate, publicly-traded company (the "Spin") in order to prepare both businesses to operate as stand-alone entities. The restructuring activities included efforts to adapt the global go-to-market footprint to adjust to the future strategies and scale of each stand-alone business; centralize certain back-office functions to increase efficiencies; outsource certain non-core transactional activities; and reduce headcount to optimize the cost structures of each stand-alone business. As of December 31, 2016 and September 30, 2016, $2.7 and $5.2 of accrued Spin restructuring charges were included in Other current liabilities.

7

Restructuring

In November 2012, the Company's Board of Directors (the "Board") authorized an enterprise-wide restructuring plan (the "Restructuring"). The Restructuring originally included several initiatives focused on reducing costs in general and administrative functions, as well as reducing manufacturing and operating costs associated with the Company's discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges specific to Edgewell have primarily related to plant closure and accelerated depreciation charges and severance and related benefit costs. Project-to-date restructuring costs total $147.0. The Company now expects full year restructuring costs to total $20.0 to $25.0 for 2017, and does not currently expect costs in future periods to be material.

Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave and Feminine Care segments for the three months ended December 31, 2016 and 2015. The Company does not include restructuring costs in the results of its reportable segments.

	Three Months Ended December 31, 2016
	Wet Shave		Feminine Care		Total
Restructuring
Severance and related benefit costs	$	0.4	$	1.5	$	1.9
Asset impairment and accelerated depreciation	—		1.7		1.7
Consulting, program management and other exit costs	1.7		1.6		3.3
Total Restructuring	$	2.1	$	4.8	$	6.9

	Three Months Ended December 31, 2015
	Wet Shave		Feminine Care		Total
Restructuring
Severance and related benefit costs	$	10.5	$	3.1	$	13.6
Asset impairment and accelerated depreciation	—		0.7		0.7
Consulting, program management and other exit costs	0.7		3.5		4.2
Total Restructuring	$	11.2	$	7.3	$	18.5

In addition, pre-tax costs of $0.3 for the three months ended December 31, 2016 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring were included in Cost of products sold. There were no obsolescence charges recorded during the three months ended December 31, 2015.

The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for the first three months of fiscal 2017:

								Utilized
	October 1, 2016		Charge to Income		Other (1)			Cash			Non-Cash			December 31, 2016
Restructuring
Severance and termination related costs	$	16.7	$	1.9	$	(0.7	)	$	(2.0	)	$	—		$	15.9
Asset impairment and accelerated depreciation	—		1.7		—			—			(1.7		)	—
Other related costs	—		3.3		—			(3.3		)	—			—
Total Restructuring	$	16.7	$	6.9	$	(0.7	)	$	(5.3	)	$	(1.7	)	$	15.9

(1) Includes the impact of currency translation.

8

The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2016:

							Utilized
	October 1, 2015		Charge to Income		Other (1)		Cash			Non-Cash			September 30, 2016
Restructuring
Severance and termination related costs	$	13.7	$	17.0	$	0.6	$	(14.6	)	$	—		$	16.7
Asset impairment and accelerated depreciation	—		3.9		—		—			(3.9		)	—
Other related costs	—		16.1		—		(16.1		)	—			—
Total Restructuring	$	13.7	$	37.0	$	0.6	$	(30.7	)	$	(3.9	)	$	16.7

(1) Includes the impact of currency translation.

Note 4 - Income Taxes

For the three months ended December 31, 2016 and 2015, the Company had income tax expense of $11.4 and $7.0, respectively, on Earnings before income taxes of $44.9 and $30.7, respectively. The effective tax rate for the three months ended December 31, 2016 was 25.4% compared to 22.8% for the three months ended December 31, 2015. The difference between the federal statutory rate and the effective rate for both periods is due to a higher mix of earnings in lower tax rate jurisdictions and was favorably impacted by Spin costs and Restructuring charges in higher tax rate jurisdictions. In addition, the effective tax rate for both periods was impacted by favorable tax adjustments, which reduced the effective rate by approximately 4%.

Note 5 - Earnings per Share

Basic earnings per share is based on the average number of common shares outstanding during the period. Diluted earnings per share is based on the average number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent ("RSE") awards.

Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation:

	Three Months Ended December 31,
	2016	2015
Basic weighted-average shares outstanding	57.7	59.7
Effect of dilutive securities:
Share options	—	—
RSE awards	0.4	0.2
Total dilutive securities	0.4	0.2
Diluted weighted-average shares outstanding	58.1	59.9

For the three months ended December 31, 2016, the calculation of diluted weighted-average shares outstanding excludes 0.6 of share options because the effect of including these awards was anti-dilutive. For the three months ended December 31, 2016, the number of RSE awards considered anti-dilutive was immaterial. For the three months ended December 31, 2015, the calculation of diluted weighted-average shares outstanding excludes 0.4 of share options and 0.2 of RSE awards because the effect of including these awards was anti-dilutive.

9

Note 6 - Goodwill and Intangible Assets

The following table sets forth goodwill by segment:

	Wet Shave			Sun and Skin Care		Feminine Care			All Other		Total
Balance at October 1, 2016	$	965.3		$	178.0	$	207.4		$	69.6	$	1,420.3
Acquisition of Bulldog	—			17.8		—			—		17.8
Cumulative translation adjustment	(8.0		)	—		(1.0		)	—		(9.0		)
Balance at December 31, 2016	$	957.3		$	195.8	$	206.4		$	69.6	$	1,429.1

Total amortizable intangible assets were as follows: 

	December 31, 2016						September 30, 2016
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trade names and brands	$	45.4	$	12.5	$	32.9	$	14.6	$	12.2	$	2.4
Technology and patents	77.0		70.3		6.7		76.9		69.8		7.1
Customer related and other	143.9		81.2		62.7		141.8		79.6		62.2
Total amortizable intangible assets	$	266.3	$	164.0	$	102.3	$	233.3	$	161.6	$	71.7

The preliminary estimate of amortizable intangible assets related to the Bulldog acquisition was $4.4, see Note 2 of Notes to Condensed Consolidated Financial Statements for more information. Amortization expense was $4.0 and $3.6 for the three months ended December 31, 2016 and 2015, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2017 and for fiscal 2018, 2019, 2020, 2021 and 2022 is approximately $12.0, $8.5, $7.3, $6.6, $6.0 and $5.9, respectively, and $56.0 thereafter.

The Company had indefinite-lived intangible assets of $1,286.2 ($223.0 in Wet Shave, $499.8 in Sun and Skin Care, $299.9 in Feminine Care and $263.5 in All Other) at December 31, 2016, a decrease of $27.2 from September 30, 2016. Indefinite-lived intangible assets decreased $30.9 due to the conversion of the Skintimate® brand name to a definite-lived intangible asset, as noted below, and changes in foreign currency translation rates. The preliminary estimate of indefinite-lived intangible assets related to the Bulldog acquisition was $8.4; however, the Company is still in the process of determining the useful lives of the acquired intangible assets. See Note 2 of Notes to Condensed Consolidated Financial Statements for more information on the Bulldog acquisition.

Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. The Company continuously monitors changing business conditions, which may indicate that the remaining useful life of goodwill and other intangible assets may warrant revision or carrying amounts may require adjustment. During fiscal 2016 and 2015, the Company recorded impairment charges of $6.5 and $29.6, respectively, on its Skintimate® brand name, which were primarily related to the introduction of competing products in the market, resulting in share and margin declines. Based on the impairments taken in the past two years and continued competitive pressure on this brand, as of October 1, 2016 the Skintimate® brand name was converted to a definite-lived asset and assigned a useful life of 20 years. This conversion to a definite-lived intangible asset increased amortization expense by $0.4 for the three months ended December 31, 2016. During fiscal 2015, the Company also recorded impairment charges related to its Playtex® and Wet Ones® brand names. As such, the fair value of both brand names continues to be relatively close to the carrying value and these assets will continue to be sensitive in the future to changes in forecasted cash flows, as well as other assumptions used in an impairment analysis, including discount rates.

10

Note 7 - Supplemental Balance Sheet Information

	December 31, 2016			September 30, 2016
Inventories
Raw materials and supplies	$	54.0		$	50.8
Work in process	50.3			43.9
Finished products	234.7			214.5
Total inventories	$	339.0		$	309.2
Other Current Assets
Miscellaneous receivables	$	40.9		$	29.1
Prepaid expenses	53.2			49.0
Value added tax collectible from customers	23.9			22.4
Income taxes receivable	25.2			39.3
Other	8.5			3.4
Total other current assets	$	151.7		$	143.2
Property, Plant and Equipment
Land	$	27.2		$	27.8
Buildings	141.6			146.0
Machinery and equipment	904.7			913.7
Capitalized software costs	38.0			38.4
Construction in progress	43.2			36.2
Total gross property	1,154.7			1,162.1
Accumulated depreciation	(682.1		)	(676.0		)
Total property, plant and equipment, net	$	472.6		$	486.1
Other Current Liabilities
Accrued advertising, sales promotion and allowances	$	44.3		$	46.8
Accrued trade allowances	24.4			30.1
Accrued salaries, vacations and incentive compensation	26.4			56.0
Income taxes payable	11.9			19.7
Returns reserve	27.4			49.9
Restructuring reserve	18.6			21.9
Value added tax payable	25.6			25.0
Deferred compensation	26.7			26.1
Other	68.1			95.9
Total other current liabilities	$	273.4		$	371.4
Other Liabilities
Pensions and other retirement benefits	$	150.0		$	154.9
Deferred compensation	57.8			58.6
Other non-current liabilities	59.8			61.3
Total other liabilities	$	267.6		$	274.8

11

Note 8 - Debt

The detail of long-term debt was as follows:

	December 31, 2016		September 30, 2016
Senior notes, fixed interest rate of 4.7%, due 2021, net (1)	$	597.9	$	597.8
Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2)	497.0		496.9
U.S. revolving credit facility due 2020	401.0		265.0
Netherlands revolving credit facility due 2017	—		281.8
Term loan, due 2019, net (1)	184.6		184.5
Total long-term debt, including current maturities	1,680.5		1,826.0
Less current portion	—		281.8
Total long-term debt	$	1,680.5	$	1,544.2

(1) At December 31, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.1, $2.2 and $0.4, respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2, $2.3 and $0.5, respectively.

(2) At December 31, 2016 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.8.

The Company had outstanding international borrowings, recorded in Notes payable, of $18.3 and $18.5as of December 31, 2016 and September 30, 2016, respectively.

Netherlands Revolving Credit Facility

On October 20, 2016, the Company terminated its commitments under the Netherlands revolving credit facility and repaid all outstanding loans and other obligations in full, in the amount of €251.3, or approximately $277.0.

Note 9 - Retirement Plans

The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below.

The Company's net periodic pension benefit (credit) cost for these plans was as follows: 

	Three Months Ended December 31,
	2016			2015
Service cost	$	1.8		$	1.3
Interest cost	3.8			5.5
Expected return on plan assets	(7.9		)	(6.9		)
Amortization of unrecognized prior service cost	—			—
Recognized net actuarial loss	1.5			1.0
Settlement loss recognized	0.3			—
Net periodic benefit (credit) cost	$	(0.5	)	$	0.9

In fiscal 2017, the Company changed the methodology used to estimate the service and interest components of net periodic benefit (credit) cost for its pension benefits, which will result in a decrease in expense of approximately $4 during fiscal 2017. The Company believes the spot discount rate approach, which applies the specific spot rates along the yield curve used in the determination of the benefit obligations to the relevant cash flows, is a more precise application of the yield curve spot rates used in the traditional single discount rate approach. The change was accounted for prospectively as a change in accounting estimate.

12

Note 10 - Shareholders' Equity

In May 2015, the Board approved an authorization to repurchase up to 10.0 shares of the Company's common stock. This authorization replaced a prior share repurchase authorization. During the three months ended December 31, 2016, the Company repurchased 0.8 shares of its common stock for $58.0, all of which were purchased under this authorization. The Company has 4.7 shares remaining under the Board authorization to repurchase its common shares in the future. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors.

During the three months ended December 31, 2016, 0.1 shares were purchased related to the surrender of shares of common stock to satisfy tax withholding obligations in connection with the vesting of RSE awards.

During the three months ended December 31, 2016, the Company paid $0.8 cash dividends related to the vesting of RSE awards, which had been declared and accrued during prior fiscal years. The Company has not declared any dividends since the third quarter of fiscal 2015, and does not currently intend to declare dividends in the foreseeable future.

Note 11 - Accumulated Other Comprehensive Loss

The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component:

	Foreign Currency Translation Adjustments			Pension and Post-retirement Activity			Hedging Activity			Total
Balance at October 1, 2016	$	(68.1	)	$	(126.3	)	$	(2.8	)	$	(197.2	)
OCI before reclassifications (1)	(38.7		)	2.7			8.1			(27.9		)
Reclassifications to earnings	—			1.2			(0.2		)	1.0
Balance at December 31, 2016	$	(106.8	)	$	(122.4	)	$	5.1		$	(224.1	)

	Foreign Currency Translation Adjustments			Pension and Post-retirement Activity			Hedging Activity			Total
Balance at October 1, 2015	$	(69.1	)	$	(105.7	)	$	3.3		$	(171.5	)
OCI before reclassifications (1)	(10.5		)	(0.1		)	(4.4		)	(15.0		)
Reclassifications to earnings	—			0.6			2.5			3.1
Balance at December 31, 2015	$	(79.6	)	$	(105.2	)	$	1.4		$	(183.4	)

(1) OCI is defined as other comprehensive income (loss).

13

The following table presents the reclassifications out of AOCI:

	For the Three Months Ended December 31,						Affected Line Item in the Condensed Consolidated Statements of Earnings
Details of AOCI Components	2016			2015
Gains and losses on cash flow hedges
Foreign exchange contracts	$	(0.3	)	$	3.6		Other income, net
	(0.3		)	3.6			Total before tax
	0.1			(1.1		)	Tax expense
	$	(0.2	)	$	2.5		Net of tax
Amortization of defined benefit pension and postretirement items
Prior service costs	$	—		$	—		(1)
Actuarial losses	1.5			1.0			(1)
Settlement loss recognized	0.3			—			(1)
	1.8			1.0			Total before tax
	(0.6		)	(0.4		)	Tax expense
	$	1.2		$	0.6		Net of tax
Total reclassifications for the period	$	1.0		$	3.1		Net of tax

(1) These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Note 12 - Financial Instruments and Risk Management

At times, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and interest rate risks. The section below outlines the types of derivatives that existed at December 31, 2016 and September 30, 2016, as well as the Company's objectives and strategies for holding derivative instruments.

Foreign Currency Risk

A significant share of the Company's sales are tied to currencies other than the U.S. dollar, the Company's reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact to reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the Euro, the Japanese Yen, the British Pound, the Canadian Dollar and the Australian Dollar.

Additionally, the Company's foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary's local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary's local currency results in an exchange gain or loss recorded in Other income, net. The primary currency to which the Company's foreign subsidiaries are exposed is the U.S. dollar.

Interest Rate Risk

The Company has interest rate risk with respect to interest expense on variable rate debt. At December 31, 2016, the Company had $585.6 of variable rate debt outstanding, which consisted of outstanding borrowings under the Company's revolving credit facility in the U.S. and term loan.

14

Cash Flow Hedges

At December 31, 2016, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective for accounting purposes in offsetting the associated risk.

The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $7.7 at December 31, 2016 compared to an unrealized loss of $4.3 at September 30, 2016 on these forward currency contracts accounted for as cash flow hedges included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at December 31, 2016 levels over the next twelve months, approximately $7.4 of the pre-tax loss included in AOCI at December 31, 2016 is expected to be included in Other income, net. Contract maturities for these hedges extend into fiscal 2018. There were 72 open foreign currency contracts at December 31, 2016 with a total notional value of $132.0.

Derivatives not Designated as Hedges

The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures, thus they are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three months ended December 31, 2016 resulted in a gain of $2.6 and was recorded in Other income, net. The change in estimated fair value of the foreign currency contracts for the three months ended December 31, 2015 was immaterial. There were five open foreign currency derivative contracts, which were not designated as cash flow hedges at December 31, 2016, with a total notional value of $84.8.

The following table provides estimated fair values and the amounts of gains and losses on derivative instruments classified as cash flow hedges:

	At December 31, 2016			For the Three Months Ended December 31, 2016
Derivatives designated as cash flow hedging relationships	Estimated Fair Value, Asset (1) (2)			Gain Recognized in OCI		Loss Reclassified From OCI into Income (Effective Portion) (3) (4)
Foreign currency contracts	$	7.7		$	11.7	$	(0.3	)
	At September 30, 2016			For the Three Months Ended December 31, 2015
Derivatives designated as cash flow hedging relationships	Estimated Fair Value, Liability (1) (2)			Gain Recognized in OCI		Gain Reclassified From OCI into Income (Effective Portion) (3) (4)
Foreign currency contracts	$	(4.3	)	$	0.8	$	3.6

(1) All derivative assets are presented in Other current assets or Other assets.

(2) All derivative liabilities are presented in Other current liabilities or Other liabilities.

(3) (Loss) gain reclassified to income was recorded in Other income, net.

(4) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.

15

The following table provides estimated fair values and the amounts of gains and losses on derivative instruments not classified as cash flow hedges:

	At December 31, 2016			For the Three Months Ended December 31, 2016
Derivatives not designated as cash flow hedging relationships	Estimated Fair Value, Asset			Gain Recognized in Income (1)
Foreign currency contracts	$	2.8		$	2.6
	At September 30, 2016			For the Three Months Ended December 31, 2015
Derivatives not designated as cash flow hedging relationships	Estimated Fair Value, Liability			Gain Recognized in Income (1)
Foreign currency contracts	$	(1.3	)	$	—

(1) Gain recognized in income was recorded in Other income, net.

The following table provides financial assets and liabilities for balance sheet offsetting:

Offsetting of derivative assets
		At December 31, 2016									At September 30, 2016
Description	Balance Sheet location	Gross amounts of recognized assets			Gross amounts offset in the Balance Sheet			Net amounts of assets presented in the Balance Sheet			Gross amounts of recognized assets			Gross amounts offset in the Balance Sheet		Net amounts of assets presented in the Balance Sheet
Foreign currency contracts	Other current assets, Other assets	$	11.9		$	(0.5	)	$	11.4		$	1.7		$	—	$	1.7
Offsetting of derivative liabilities
		At December 31, 2016									At September 30, 2016
Description	Balance Sheet location	Gross amounts of recognized liabilities			Gross amounts offset in the Balance Sheet			Net amounts of liabilities presented in the Balance Sheet			Gross amounts of recognized liabilities			Gross amounts offset in the Balance Sheet		Net amounts of liabilities presented in the Balance Sheet
Foreign currency contracts	Other current liabilities, Other liabilities	$	(0.9	)	$	—		$	(0.9	)	$	(6.2	)	$	0.2	$	(6.0	)

16

Fair Value Hierarchy

Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets.

Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy:

	December 31, 2016			September 30, 2016
Assets (Liabilities) at estimated fair value:
Deferred compensation	$	(84.3	)	$	(84.5	)
Derivatives - foreign currency contracts	10.5			(5.6		)
Net liabilities at estimated fair value	$	(73.8	)	$	(90.1	)

At December 31, 2016 and September 30, 2016, the Company had no level 1 or level 3 financial assets or liabilities, other than pension plan assets.

At December 31, 2016 and September 30, 2016, the fair market value of fixed rate long-term debt was $1,126.3 and $1,106.2, respectively, compared to its carrying value of $1,094.9 and $1,094.7, respectively. The estimated fair value of the long-term debt is estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of variable-rate debt, excluding revolving credit facilities, which consists of bank debt, was $185.0 compared to its carrying value of $184.6 and $184.5 at December 31, 2016 and September 30, 2016, respectively. The estimated fair value is equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on level 2 inputs.

Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company's revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings and the revolving credit agreements have been determined based on level 2 inputs.

At December 31, 2016, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan.

17

Note 13 - Commitments and Contingencies

The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, if the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to the Company's financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

Note 14 - Segment Data

The Company conducts its business in the following four segments:

• Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.

• Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves.

• Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.

• All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.

Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.

The Company's operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and in most cases a combined sales force and management teams. The Company applies a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis.

18

Segment net sales and profitability are presented below:

	Three Months Ended December 31,
	2016			2015
Net Sales
Wet Shave	$	306.2		$	316.3
Sun and Skin Care	57.6			53.5
Feminine Care	89.1			92.5
All Other	32.1			32.8
Total net sales	$	485.0		$	495.1
Segment Profit
Wet Shave	$	72.0		$	66.8
Sun and Skin Care	0.8			1.7
Feminine Care	8.3			17.6
All Other	6.9			7.2
Total segment profit	88.0			93.3
General corporate and other expenses	(16.4		)	(17.7		)
Spin costs (1)	—			(7.5		)
Restructuring and related costs (2)	(7.2		)	(18.5		)
Amortization of intangibles	(4.0		)	(3.6		)
Interest and other expense, net	(15.5		)	(15.3		)
Total earnings before income taxes	$	44.9		$	30.7

(1) Includes pre-tax Selling, general and administrative expense of $7.3 and pre-tax Cost of products sold of $0.2 for the three months ended December 31, 2015 related to the separation of the Household Products business in July 2015.

(2) Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the three months ended December 31, 2016.

Supplemental product information is presented below for net sales:

	Three Months Ended December 31,
	2016		2015
Razors and blades	$	271.3	$	274.2
Tampons, pads and liners	89.1		92.5
Sun care products	37.7		36.9
Infant care and other	32.1		32.7
Shaving gels and creams	34.9		42.2
Skin care products	19.9		16.6
Total net sales	$	485.0	$	495.1

19

Note 15 - Guarantor and Non-Guarantor Financial Information

The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture.

Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of the Parent Company, Edgewell Personal Care Company, the Guarantors on a combined basis, the Non-Guarantors on a combined basis and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors.

20

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

Three Months Ended December 31, 2016

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	342.9		$	232.3		$	(90.2	)	$	485.0
Cost of products sold	—			204.5			142.7			(90.2		)	257.0
Gross profit	—			138.4			89.6			—			228.0
Selling, general and administrative expense	—			58.7			35.1			—			93.8
Advertising and sales promotion expense	—			30.2			20.4			—			50.6
Research and development expense	—			16.0			0.3			—			16.3
Restructuring charges	—			2.7			4.2			—			6.9
Interest expense associated with debt	13.4			3.3			0.7			—			17.4
Other expense (income), net	—			0.4			(2.3		)	—			(1.9		)
Intercompany service fees	—			(4.4		)	4.4			—			—
Equity in earnings of subsidiaries	(41.9		)	(21.1		)	—			63.0			—
Earnings before income taxes	28.5			52.6			26.8			(63.0		)	44.9
Income tax (benefit) provision	(5.0		)	10.9			5.5			—			11.4
Net earnings	$	33.5		$	41.7		$	21.3		$	(63.0	)	$	33.5
Statement of Comprehensive Income:
Net earnings	$	33.5		$	41.7		$	21.3		$	(63.0	)	$	33.5
Other comprehensive loss, net of tax	(26.9		)	(3.2		)	(27.8		)	31.0			(26.9		)
Total comprehensive income	$	6.6		$	38.5		$	(6.5	)	$	(32.0	)	$	6.6

21

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

Three Months Ended December 31, 2015

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	336.8		$	269.5		$	(111.2	)	$	495.1
Cost of products sold	—			204.9			174.8			(112.1		)	267.6
Gross profit	—			131.9			94.7			0.9			227.5
Selling, general and administrative expense	3.1			60.7			36.6			—			100.4
Advertising and sales promotion expense	—			27.5			19.2			(0.1		)	46.6
Research and development expense	—			15.6			0.4			—			16.0
Restructuring charges	—			4.7			13.8			—			18.5
Interest expense associated with debt	16.2			—			1.5			—			17.7
Other income, net	—			(2.4		)	—			—			(2.4		)
Intercompany service fees	—			(5.5		)	5.5			—			—
Equity in earnings of subsidiaries	(35.8		)	(12.4		)	—			48.2			—
Earnings before income taxes	16.5			43.7			17.7			(47.2		)	30.7
Income tax (benefit) provision	(7.2		)	10.0			3.2			1.0			7.0
Net earnings	$	23.7		$	33.7		$	14.5		$	(48.2	)	$	23.7
Statement of Comprehensive Income:
Net earnings	23.7			33.7			14.5			(48.2		)	23.7
Other comprehensive loss, net of tax	(11.9		)	(1.9		)	(11.5		)	13.4			(11.9		)
Total comprehensive income	$	11.8		$	31.8		$	3.0		$	(34.8	)	$	11.8

22

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING BALANCE SHEETS

December 31, 2016

	Parent Company		Guarantors		Non-Guarantors		Eliminations			Total
Assets
Current assets
Cash and cash equivalents	$	—	$	5.1	$	413.4	$	—		$	418.5
Trade receivables, net	—		102.2		126.2		—			228.4
Inventories	—		210.8		128.2		—			339.0
Other current assets	—		41.8		109.9		—			151.7
Total current assets	—		359.9		777.7		—			1,137.6
Investment in subsidiaries	3,500.2		841.9		—		(4,342.1		)	—
Intercompany receivables, net (1)	—		579.0		42.7		(621.7		)	—
Intercompany notes receivable (1)	—		1.9		—		(1.9		)	—
Property, plant and equipment, net	—		341.8		130.8		—			472.6
Goodwill	—		1,061.9		367.2		—			1,429.1
Other intangible assets, net	—		1,231.5		157.0		—			1,388.5
Other assets	1.8		0.2		25.4		—			27.4
Total assets	$	3,502.0	$	4,418.1	$	1,500.8	$	(4,965.7	)	$	4,455.2
Liabilities and Shareholders' Equity
Current liabilities	$	7.8	$	236.3	$	229.2	$	—		$	473.3
Intercompany payables, net (1)	621.7		—		—		(621.7		)	—
Intercompany notes payable (1)	—		—		1.9		(1.9		)	—
Long-term debt	1,094.5		586.0		—		—			1,680.5
Deferred income tax liabilities	—		229.7		26.1		—			255.8
Other liabilities	—		231.6		36.0		—			267.6
Total liabilities	1,724.0		1,283.6		293.2		(623.6		)	2,677.2
Total shareholders' equity	1,778.0		3,134.5		1,207.6		(4,342.1		)	1,778.0
Total liabilities and shareholders' equity	$	3,502.0	$	4,418.1	$	1,500.8	$	(4,965.7	)	$	4,455.2

(1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

23

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING BALANCE SHEETS

September 30, 2016

	Parent Company		Guarantors		Non-Guarantors		Eliminations			Total
Assets
Current assets
Cash and cash equivalents	$	—	$	5.8	$	733.1	$	—		$	738.9
Trade receivables, net	—		108.9		151.8		—			260.7
Inventories	—		187.7		121.5		—			309.2
Other current assets	—		43.7		99.5		—			143.2
Total current assets	—		346.1		1,105.9		—			1,452.0
Investment in subsidiaries	3,483.7		825.0		—		(4,308.7		)	—
Intercompany receivables, net (1)	—		487.6		53.5		(541.1		)	—
Intercompany notes receivable (1)	—		1.9		—		(1.9		)	—
Property, plant and equipment, net	—		343.8		142.3		—			486.1
Goodwill	—		1,061.9		358.4		—			1,420.3
Other intangible assets, net	—		1,235.1		150.0		—			1,385.1
Other assets	2.0		0.1		25.9		—			28.0
Total assets	$	3,485.7	$	4,301.5	$	1,836.0	$	(4,851.7	)	$	4,771.5
Liabilities and Shareholders' Equity
Current liabilities	$	21.4	$	288.4	$	558.4	$	—		$	868.2
Intercompany payables, net (1)	541.1		—		—		(541.1		)	—
Intercompany notes payable (1)	—		—		1.9		(1.9		)	—
Long-term debt	1,094.2		450.0		—		—			1,544.2
Deferred income tax liabilities	—		232.4		22.9		—			255.3
Other liabilities	—		236.3		38.5		—			274.8
Total liabilities	1,656.7		1,207.1		621.7		(543.0		)	2,942.5
Total shareholders' equity	1,829.0		3,094.4		1,214.3		(4,308.7		)	1,829.0
Total liabilities and shareholders' equity	$	3,485.7	$	4,301.5	$	1,836.0	$	(4,851.7	)	$	4,771.5

(1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

24

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Three Months Ended December 31, 2016

	Parent Company			Guarantors			Non-Guarantors			Eliminations		Total
Net cash flow from (used by) operations	$	58.0		$	(124.8	)	$	7.8		$	—	$	(59.0	)
Cash Flow from Investing Activities
Capital expenditures	—			(11.0		)	(2.7		)	—		(13.7		)
Acquisitions, net of cash acquired	—			—			(34.0		)	—		(34.0		)
Net cash used by investing activities	—			(11.0		)	(36.7		)	—		(47.7		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	—			146.0			—			—		146.0
Cash payments on debt with original maturities greater than 90 days	—			(10.0		)	(277.0		)	—		(287.0		)
Net (decrease) increase in debt with original maturities of 90 days or less	—			(0.9		)	0.5			—		(0.4		)
Common shares purchased	(58.0		)	—			—			—		(58.0		)
Net cash (used by) from financing activities	(58.0		)	135.1			(276.5		)	—		(199.4		)
Effect of exchange rate changes on cash	—			—			(14.3		)	—		(14.3		)
Net decrease in cash and cash equivalents	—			(0.7		)	(319.7		)	—		(320.4		)
Cash and cash equivalents, beginning of period	—			5.8			733.1			—		738.9
Cash and cash equivalents, end of period	$	—		$	5.1		$	413.4		$	—	$	418.5

25

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Three Months Ended December 31, 2015

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net cash flow from (used by) operations	$	78.9		$	(123.7	)	$	(13.9	)	$	—		$	(58.7	)
Cash Flow from Investing Activities
Capital expenditures	—			(13.0		)	(1.5		)	—			(14.5		)
Payment for equity contributions	—			(0.2		)	—			0.2			—
Net cash used by investing activities	—			(13.2		)	(1.5		)	0.2			(14.5		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	—			345.0			2.8			—			347.8
Cash payments on debt with original maturities greater than 90 days	—			(203.0		)	—			—			(203.0		)
Net (decrease) increase in debt with original maturities of 90 days or less	—			(2.4		)	0.2			—			(2.2		)
Common shares purchased	(78.9		)	—			—			—			(78.9		)
Proceeds for equity contributions	—			—			0.2			(0.2		)	—
Net cash (used by) from financing activities	(78.9		)	139.6			3.2			(0.2		)	63.7
Effect of exchange rate changes on cash	—			—			(8.4		)	—			(8.4		)
Net increase (decrease) in cash and cash equivalents	—			2.7			(20.6		)	—			(17.9		)
Cash and cash equivalents, beginning of period	—			2.9			709.2			—			712.1
Cash and cash equivalents, end of period	$	—		$	5.6		$	688.6		$	—		$	694.2

26

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

(in millions, except per share data, unaudited)

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes included in this Quarterly Report on Form 10-Q, and our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on November 18, 2016. The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs and involve risks, uncertainties and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within "Forward-Looking Statements" below, and in Item 1A. Risk Factors and "Forward-Looking Statements" included within our Annual Report on Form 10-K.

Non-GAAP Financial Measures. While we report financial results in accordance with accounting principles generally accepted in the United States ("reported" or "GAAP"), this discussion also includes Non-GAAP measures. These Non-GAAP measures are referred to as "adjusted" or "organic" and exclude items such as spin costs, restructuring charges and amortization of intangibles. Reconciliations of Non-GAAP measures are included within this Management's Discussion and Analysis of Financial Condition and Results of Operations.

This Non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this Non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This Non-GAAP information is a component in determining management's incentive compensation. Finally, we believe this information provides a higher degree of transparency. The following provides additional detail on our Non-GAAP measures:

• We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and segment profit exclude the impact of changes in foreign currency and acquisitions. This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.

• Adjusted net earnings and adjusted earnings per share are defined as net earnings and diluted earnings per share excluding items such as spin costs, restructuring charges and the related tax effects of these items.

• Adjusted effective tax rate is defined as the effective tax rate excluding items such as spin costs, restructuring charges and the related tax effects of these items from the income tax provision and earnings before income taxes.

All comparisons are with the same period in the prior year, unless otherwise noted.

Industry and Market Data. Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share and industry market size is based on our estimates using internal data and data from various industry analyses, our internal research and adjustments and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in the "Risk Factors" section of our Annual Report on Form 10-K. These and other factors could cause results to differ materially from those expressed in the estimates and assumptions.

Retail sales for purposes of market size, market position and market share information are based on retail sales in United States ("U.S.") dollars.

Trademarks and Trade Names. We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We also may refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.

27

Forward-Looking Statements. This document contains both historical and forward-looking statements. Forward-looking statements are not based on historical facts, but instead reflect our expectations, estimates or projections concerning future results or events, including, without limitation, the future earnings and performance of Edgewell Personal Care Company or any of our businesses. These statements generally can be identified by the use of forward-looking words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "will," "should," "forecast," "outlook," or other similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances. Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation:

• We are subject to risks related to our international operations, such as global economic conditions and currency fluctuations, that could adversely affect our results of operations;

• Competition within our industries may hinder our ability to execute our business strategy, achieve profitability or maintain relationships with existing customers;

• Loss of reputation of our leading brands or failure of our marketing plans could have an adverse effect on our business;

• Our manufacturing facilities, supply channels or other business operations may be subject to disruption from events beyond our control;

• Our access to capital markets and borrowing capacity could be limited;

• If we cannot continue to develop new products in a timely manner, and at favorable margins, we may not be able to compete effectively;

• We have a substantial level of indebtedness and are subject to various covenants relating to such indebtedness, which could limit our discretion to operate and grow our business;

• We face risks arising from the restructuring of our operations and our ongoing efforts to achieve cost savings;

• Loss of any of our principal customers and emergence of new sales channels, such as e-commerce, could significantly decrease our sales and profitability;

• We may not be able to attract, retain and develop key personnel;

• We may experience losses or be subject to increased funding obligations and expenses related to our pension plans;

• We may not be able to continue to identify and complete strategic acquisitions and effectively integrate acquired companies to achieve desired financial benefits;

• Our business involves the potential for product liability and other claims against us, which could affect our results of operations and financial condition and result in product recalls or withdrawals;

• A failure of a key information technology system or a breach of our information security could adversely impact our ability to conduct business;

• Our business is subject to increasing regulation in the U.S. and abroad, including environmental laws and regulations, that may expose us to significant liabilities;

• The resolution of our tax contingencies may result in additional tax liabilities, which could adversely impact our cash flows and results of operations;

• If we fail to adequately protect our intellectual property rights, competitors may manufacture and market similar products, which could adversely affect our market share and results of operations;

• Our financial results could be negatively impacted by the United Kingdom's departure from the European Union; and

• We face risks related to the separation of our Household Products business, which may adversely affect our business.

In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the accuracy of any such forward-looking statements. The list of factors above is illustrative, but not exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Additional risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our Annual Report on Form 10-K.

28

Overview

Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. We have a portfolio of over 25 brands and a broad global footprint that operates in more than 50 countries.

We conduct our business in the following four segments:

• Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. Our wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.

• Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves.

• Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.

• All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.

The personal care product categories are highly competitive, both in the U.S. and on a global basis, as large manufacturers with global operations compete for consumer acceptance and, increasingly, limited retail shelf space. Competition is based upon brand perception, product performance, customer service and price. The markets are generally characterized by the frequent introduction of new products, accompanied by major advertising and promotional programs. Our priority is to deliver our strategic objectives, focusing on maximizing sales and profit growth through innovation, product line extensions and share gains, and we continue to target improved working capital management as a key business objective.

Significant Events

Acquisition of Bulldog

On October 31, 2016, we completed the acquisition of Bulldog Skincare Holdings Limited ("Bulldog"), a men's grooming and skincare products company based in the United Kingdom (the "U.K.") for £27.8, or $34.0, net of cash acquired. The acquisition creates opportunities to expand our personal care portfolio into a growing global category where we can leverage our international geographic footprint. The acquisition was financed through available foreign cash. The results of Bulldog for the post-acquisition period are included within our results for the first quarter of fiscal 2017. For more information on the acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements.

Skintimate® Trade Name

Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. During fiscal 2016 and 2015, we recorded impairment charges of $6.5 and $29.6, respectively, on our Skintimate® brand name, which were primarily related to the introduction of competing products in the market, which resulted in share and margin declines. Based on the impairments taken in the past two years and continued competitive pressure on this brand, as of October 1, 2016 the Skintimate® brand name was converted to a definite-lived asset and assigned a useful life of 20 years. This conversion to a definite-lived intangible asset increased amortization expense by $0.4 during the first quarter of fiscal 2017.

Restructuring Projects

In November 2012, our Board of Directors (the "Board") authorized an enterprise-wide restructuring plan and delegated authority to management to determine the final actions with respect to this plan (the "Restructuring"). The Restructuring originally included several initiatives focused on reducing costs in general and administrative functions as well as reducing manufacturing and operating costs associated with our discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced the Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges specific to Edgewell have primarily related to plant closure and accelerated depreciation charges and severance and related benefit costs.

29

During the first quarter of fiscal 2017, we incurred $7.2 of charges related to the Restructuring, which includes $0.3 associated with non-core inventory obsolescence charges included within Cost of products sold, and estimate our incremental additional gross savings in the first quarter of fiscal 2017 under the Restructuring to be approximately $5.0. Project-to-date restructuring costs total $147.0. We now expect full year costs of $20.0 to $25.0 in fiscal 2017, and do not currently expect costs in future periods to be material. Project-to-date savings total approximately $133.0. We expect full year savings of approximately $20.0 to $25 in fiscal 2017, with an additional $20.0 to $25.0 in fiscal 2018 and 2019, combined. The transition of manufacturing in our Feminine Care segment from Montreal to Dover, Delaware is approximately two to three months behind schedule and, as a result, project costs have increased and some anticipated savings are now expected to be realized in fiscal 2019. The remainder of our restructuring projects, which relate to Wet Shave and Sun Care footprint changes, are expected to be on schedule.

For further information on our restructuring projects, see Note 3 of Notes to Condensed Consolidated Financial Statements.

Executive Summary

Following is a summary of key results for the first quarter of fiscal 2017. Net earnings and earnings per share ("EPS") for the time periods presented were impacted by restructuring activities, costs related to the separation of the Household Products business in July 2015, and the related tax impact from those costs as described in the table below. The impact of these items on reported net earnings and EPS are provided below as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, which are Non-GAAP measures.

First Quarter of Fiscal 2017

• Net sales in the first quarter of fiscal 2017 decreased2.0% to $485.0, inclusive of a 0.6% increase as a result of the acquisition of Bulldog and a 0.5% decrease due to currency movements. Excluding the impact of the acquisition and currency movements, organic net sales decreased2.1% in the first quarter as compared to the prior year period, as growth in North America Wet Shave and global Sun and Skin Care was offset by declines in International Wet Shave and Feminine Care.

• Net earnings in the first quarter of fiscal 2017 were $33.5 as compared to $23.7 in the prior year. On an adjusted basis, as illustrated in the table below, net earnings for the first quarter of fiscal 2017 decreased6.3% to $38.4. The decline in adjusted net earnings for the quarter is primarily due to lower organic net sales and increased Advertising and sales promotion expense ("A&P") investments in the current year.

• Net earnings per diluted share during the first quarter of fiscal 2017 were $0.58 compared to $0.39 in the prior year period. On an adjusted basis, as illustrated in the table below, net earnings per diluted share during the first quarter of fiscal 2017 were $0.66 compared to $0.68 in the prior year.

	Net Earnings						Diluted EPS
	Q1 2017			Q1 2016			Q1 2017			Q1 2016
Net Earnings and Diluted EPS - GAAP	$	33.5		$	23.7		$	0.58		$	0.39
Spin costs (1)	—			7.5			—			0.13
Restructuring and related costs (2)	7.2			18.5			0.12			0.31
Income taxes	(2.3		)	(8.7		)	(0.04		)	(0.15		)
Adjusted Net Earnings and Adjusted Diluted EPS - Non-GAAP	$	38.4		$	41.0		$	0.66		$	0.68
Weighted-average shares outstanding - Diluted							58.1			59.9

(1) Includes pre-tax Selling, general and administrative expense ("SG&A") of $7.3 and pre-tax Cost of products sold of $0.2 for the first quarter of fiscal 2016 related to the separation of the Household Products business in July 2015.

(2) Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the three months ended December 31, 2016.

30

Operating Results

The following table presents changes in net sales for the first quarter of fiscal 2017, as compared to the corresponding period in fiscal 2016, and also provides a reconciliation of organic net sales to reported amounts.

Net Sales

Net Sales - Total Company
Quarter Ended December 31, 2016
	Q1			%Chg
Net sales - prior year	$	495.1
Organic	(10.6		)	(2.1	)%
Impact of acquisition	3.2			0.6	%
Impact of currency	(2.7		)	(0.5	)%
Net sales - current year	$	485.0		(2.0	)%

For the first quarter of fiscal 2017, net sales decreased2.0%. Excluding the impact of the acquisition of Bulldog and currency movements, organic net sales decreased2.1% versus the prior year period. Growth in North America Wet Shave and global Sun and Skin Care was more than offset by declines in International Wet Shave and Feminine Care.

For further discussion regarding net sales, including a summary of reported versus organic changes, see "Segment Results."

Gross Profit

Gross profit was $228.0 during the first quarter of fiscal 2017, as compared to $227.5 in the prior year period. Gross margin as a percent of net sales for the first quarter of fiscal 2017 was 47.0%, representing a 100 basis point improvement over the prior year gross margin of 46.0%. This improvement was driven by a favorable cost mix due to lower material costs and incremental restructuring savings, as well as favorable transactional currency impacts, partially offset by higher product costs associated with the shift of Feminine Care manufacturing from Montreal to Dover, Delaware.

Selling, General and Administrative Expense

SG&A was $93.8 in the first quarter of fiscal 2017, or 19.3% of net sales, as compared to $100.4 in the prior year period, or 20.3% of net sales. Included in SG&A in the first quarter of fiscal 2016 was approximately $7.3 of pre-tax costs related to the separation of the Household Products business in July 2015. Excluding these costs, SG&A was $93.1, or 18.8% of net sales, for the prior year period, relatively consistent with the current quarter.

Advertising and Sales Promotion Expense

For the first quarter of fiscal 2017, A&P was $50.6, up$4.0 as compared to the prior year period. A&P spending as a percent of net sales was 10.4% compared to 9.4% in the prior year period. The increased spending was primarily focused on our Sun and Skin Care and Feminine Care segments.

Research and Development Expense

Research and development expense ("R&D") for the first quarter of fiscal 2017 was relatively consistent over the prior period with spending at $16.3 compared to $16.0 in the prior year period. As a percent of sales, R&D was 3.4% in the current quarter and 3.2% in the prior year period.

31

Interest and Other Income, Net

Interest expense associated with debt for the first quarter of fiscal 2017 was $17.4, a slight decrease from the prior year period expense of $17.7 due to lower average debt outstanding. Other income, net was $1.9 during the first quarter of fiscal 2017 and $2.4 during the first quarter of fiscal 2016. The slight decrease reflects the net impact of foreign currency hedging contract gains and losses.

Income Tax Provision

The effective tax rate for the first quarters of fiscal 2017 and 2016 was 25.4% and 22.8%, respectively. The effective tax rate for the first quarter of 2016 includes a higher amount of costs related to the separation of the Household Products business in July 2015 and restructuring charges in higher tax rate jurisdictions. Excluding these costs, the adjusted effective tax rate was 26.3% and 27.7% for the first quarters of fiscal 2017 and 2016, respectively. The 140 basis point decrease is primarily due to a more favorable mix of earnings in lower tax rate jurisdictions. Our effective tax rate for fiscal 2017 is expected to be in the range of 27% to 28%; however, the adjusted effective tax rate is dependent upon the mix of earnings in various tax jurisdictions.

The following table presents a reconciliation of the adjusted effective tax rate, which is a Non-GAAP measure:

	Q1 2017								Q1 2016
	Reported			Adjustments (1)		Adjusted (Non-GAAP)			Reported			Adjustments (1)		Adjusted (Non-GAAP)
Earnings before income taxes	$	44.9		$	7.2	$	52.1		$	30.7		$	26.0	$	56.7
Income tax provision	11.4			2.3		13.7			7.0			8.7		15.7
Net earnings	$	33.5		$	4.9	$	38.4		$	23.7		$	17.3	$	41.0
Effective tax rate	25.4		%						22.8		%
Adjusted effective tax rate						26.3		%						27.7		%

(1) Includes adjustments for spin costs, restructuring charges and the associated tax impact of these charges. See reconciliation of net earnings to adjusted net earnings.

Segment Results

Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.

Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis.

The following tables present changes in segment net sales and segment profit for the first quarter of fiscal 2017, as compared to the corresponding period in fiscal 2016, and also provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, see Note 14 of Notes to Condensed Consolidated Financial Statements.

32

Wet Shave

Net Sales - Wet Shave
Quarter Ended December 31, 2016
	Q1			%Chg
Net sales - prior year	$	316.3
Organic	(7.7		)	(2.4	)%
Impact of currency	(2.4		)	(0.8	)%
Net sales - current year	$	306.2		(3.2	)%

Wet Shave net sales for the first quarter of fiscal 2017 decreased3.2%, inclusive of a 0.8%decline due to currency movements. Excluding the impact of currency movements, organic net sales decreased $7.7, or 2.4%. The decrease in organic net sales was largely driven by $7.5 in lower sales of shaving gels and creams due primarily to distribution losses in the prior fiscal year, as well as increased competitive pressure. North America organic net sales increased 3.8%, driven by higher volumes and share gains in men's and women's systems and disposables, offset by declines in shaving gels and creams. International organic net sales declined 8.2%, primarily driven by lower volumes in both men's systems and shaving gels and creams in Asia due in part to the timing of shipments related to an upcoming price increase in Japan, as well as competitive pressure.

Segment Profit - Wet Shave
Quarter Ended December 31, 2016
	Q1		%Chg
Segment profit - prior year	$	66.8
Organic	4.3		6.4	%
Impact of currency	0.9		1.4	%
Segment profit - current year	$	72.0	7.8	%

Wet Shave segment profit for the first quarter of fiscal 2017 was $72.0, up$5.2 or 7.8%, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit increased$4.3, or 6.4%, primarily due to lower material costs, favorable transactional currency impacts and restructuring savings, which were partially offset by decreased volumes.

Sun and Skin Care

Sun and Skin Care segment net sales and segment profit are affected by the seasonality of sun care products. As a result, segment net sales and segment profit tend to be higher in the second and third quarters of the fiscal year.

Net Sales - Sun and Skin Care
Quarter Ended December 31, 2016
	Q1			%Chg
Net sales - prior year	$	53.5
Organic	1.0			1.9	%
Impact of acquisition	3.2			6.0	%
Impact of currency	(0.1		)	(0.2	)%
Net sales - current year	$	57.6		7.7	%

Sun and Skin Care net sales for the first quarter of fiscal 2017 increased7.7%, inclusive of a 6.0% increase due to the acquisition of Bulldog and a 0.2%decline due to currency movements. Excluding the impact of the acquisition and currency movements, organic net sales increased$1.0, or 1.9%, driven by volume growth in International, which was partially offset by a $2.0 decline in North America due to a shift in timing of shipments between quarters, as well as the decision to exit the private label sun care business.

33

Segment Profit - Sun and Skin Care
Quarter Ended December 31, 2016
	Q1			%Chg
Segment profit - prior year	$	1.7
Organic	(0.3		)	(17.6	)%
Impact of acquisition	(0.4		)	(23.5	)%
Impact of currency	(0.2		)	(11.8	)%
Segment profit - current year	$	0.8		(52.9	)%

Segment profit for the first quarter of fiscal 2017 was $0.8, a decrease of $0.9 or 52.9%, inclusive of the impact of the acquisition of Bulldog and currency movements. Excluding the impact of the acquisition and currency movements, organic segment profit decreased$0.3, or 17.6%, driven primarily by higher planned A&P spend to support International sales growth, which was partially offset by restructuring savings.

Feminine Care

Net Sales - Feminine Care
Quarter Ended December 31, 2016
	Q1			%Chg
Net sales - prior year	$	92.5
Organic	(3.4		)	(3.7	)%
Impact of currency	—			—	%
Net sales - current year	$	89.1		(3.7	)%

Feminine Care net sales for the first quarter of fiscal 2017 decreased3.7%, due to lower volumes on tampons and liners. Sport® branded pads and liner volumes were down approximately $2.0 due to distribution losses, which are expected to continue for the remainder of the fiscal year. Tampon net sales were also down, due to competitive pressure and soft consumption in the quarter. These declines were partly offset by higher volume in Stayfree® pads and Carefree® liners.

Segment Profit - Feminine Care
Quarter Ended December 31, 2016
	Q1			%Chg
Segment profit - prior year	$	17.6
Organic	(9.3		)	(52.8	)%
Impact of currency	—			—	%
Segment profit - current year	$	8.3		(52.8	)%

Feminine Care segment profit for the first quarter of fiscal 2017 was $8.3, a decrease of $9.3 or 52.8%, primarily due to increased product costs, higher A&P spending, primarily related to Carefree®, and the lower volumes noted above. Product costs were unfavorable as higher plant startup costs related to the transition of manufacturing from Montreal to Dover, Delaware were only partially offset by restructuring savings and lower material costs. These startup costs are expected to impact segment profitability for the next two quarters.

34

All Other

Net Sales - All Other
Quarter Ended December 31, 2016
	Q1			%Chg
Net sales - prior year	$	32.8
Organic	(0.5		)	(1.5	)%
Impact of currency	(0.2		)	(0.6	)%
Net sales - current year	$	32.1		(2.1	)%

All Other net sales for the first quarter of fiscal 2017 decreased2.1%, inclusive of a 0.6%decline due to the impact of currency movements.Excluding the impact of currency movements, organic net sales decreased$0.5 or 1.5%, as lower volumes in infant cups and bottles resulting from continued competition in the category were partially offset by growth in Diaper Genie®.

Segment Profit - All Other
Quarter Ended December 31, 2016
	Q1			%Chg
Segment profit - prior year	$	7.2
Organic	(0.3		)	(4.2	)%
Impact of currency	—			—	%
Segment profit - current year	$	6.9		(4.2	)%

All Other segment profit for the first quarter of fiscal 2017 was $6.9, a decrease of $0.3 or 4.2%, primarily driven by lower net sales.

General Corporate and Other Expenses

	Q1 2017			Q1 2016
Corporate expenses	$	16.4		$	17.7
Spin costs (1)	—			7.5
Restructuring and related costs (2)	7.2			18.5
General corporate and other expenses	$	23.6		$	43.7
% of net sales	4.9		%	8.8		%

(1) Includes pre-tax SG&A of $7.3 and pre-tax Cost of products sold of $0.2 for the first quarter of fiscal 2016 related to the separation of the Household Products business in July 2015.

(2) Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the first quarter of fiscal 2017.

For the first quarter of fiscal 2017, general corporate expenses were $16.4, a decrease of $1.3 as compared to the prior year. As a percent of net sales, general corporate expenses were 3.4% during the first quarter of fiscal 2017, a slight decrease from 3.6% in the prior year period.

35

Liquidity and Capital Resources

At December 31, 2016, substantially all of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. Our intention is to reinvest earnings of our foreign subsidiaries indefinitely as the repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences or be subject to regulatory capital requirements; however, those balances are generally available without legal restrictions to fund ordinary business operations.

The counterparties to deposits consist of a number of major financial institutions. We consistently monitor positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.

Our total borrowings were $1,698.8 at December 31, 2016, including $585.6 tied to variable interest rates. Our total borrowings at September 30, 2016 were $1,844.5.

As of December 31, 2016, we had outstanding borrowings of $401.0 under our unsecured revolving credit facility in the U.S. (the "Revolving Facility") and $8.1 of outstanding letters of credit. Taking into account outstanding borrowings and outstanding letters of credit at December 31, 2016, $240.9 remains available under the Revolving Facility. At September 30, 2016, we had outstanding borrowings of $265.0 under the Revolving Facility. As of December 31, 2016 and September 30, 2016, we had approximately $185.0 outstanding under a term loan.

On October 20, 2016, we terminated our commitments under our revolving credit facility in the Netherlands (the "Netherlands Credit Facility") and repaid all outstanding loans and other obligations in full, in the amount of €251.3 (approximately $277). As of September 30, 2016, we had €250.8 (approximately $281.8) outstanding under the Netherlands Credit Facility.

We had outstanding international borrowings, recorded in Notes payable, of $18.3 and $18.5 as of December 31, 2016 and September 30, 2016, respectively.

The minimum required contribution to our pension plans in fiscal 2017 is $7.3; however, discretionary contributions may also be made. During the first quarter of fiscal 2017, we contributed $0.7 to our pension plans.

As of December 31, 2016, we were in compliance, in all material respects, with the provisions and covenants associated with our debt agreements.

Cash Flows

A summary of our cash flow from operating, investing and financing activities is provided in the following table:

	Q1 2017			Q1 2016
Net cash (used by) from:
Operating activities	$	(59.0	)	$	(58.7	)
Investing activities	(47.7		)	(14.5		)
Financing activities	(199.4		)	63.7
Effect of exchange rate changes on cash	(14.3		)	(8.4		)
Net decrease in cash and cash equivalents	$	(320.4	)	$	(17.9	)

Operating Activities

Cash flow used by operating activities was $59.0 during the first quarter of fiscal 2017 as compared to $58.7 during the same period in the prior year. The outflow in both periods reflects the impact of seasonality on our results, primarily related to sun care products. The increase in net outflow from working capital in the current quarter was driven by the timing of receipts and payments, as well as increased inventory levels. We expect to have positive operating cash flow for the full fiscal year.

36

Investing Activities

Cash flow used by investing activities was $47.7 during the first quarter of fiscal 2017 as compared to $14.5 used during the same period in the prior year. The increase was primarily due to the $34.0 acquisition of Bulldog in the first quarter of fiscal 2017. Capital expenditures were $13.7 during the first quarter of fiscal 2017 and $14.5 during the same period in the prior year, with higher capitalized software additions in fiscal 2016.

Financing Activities

Net cash used by financing activities was $199.4 during the first quarter of fiscal 2017 as compared to net cash from financing activities of $63.7 during the same period in the prior year. The $263.1 increase in net cash used by financing activities was driven by the repayment of the Netherlands Credit Facility for approximately $277.0 in the current year period, partially offset by a decrease in repurchases of common shares of $20.9 when compared to the prior year period, and net borrowings on other debt instruments.

Share Repurchases

During the first quarter of fiscal 2017, we repurchased 0.8 shares of our common stock for $58.0. We have 4.7 shares remaining under the Board authorization to repurchase our common shares in the future. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs and other factors.

During the first quarter of fiscal 2017, 0.1 shares were purchased related to the surrender of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock equivalent awards.

Foreign Currency

On June 23, 2016, the U.K. held a referendum in which voters approved an exit from the European Union (the "E.U."), commonly referred to as "Brexit". As a result of the referendum, the global markets and currencies have been adversely impacted, including a sharp decline in the value of the British Pound as compared to the U.S. dollar and other foreign currencies. Volatility in exchange rates is expected to continue as the U.K. negotiates its exit from the E.U. Our current hedging strategy includes hedging a portion of our exposure to the British Pound, thereby reducing our currency risk. We do not currently expect changes to this hedging strategy. A weaker British Pound as compared to the U.S. dollar during a reporting period causes the local currency results of our U.K. operations to be translated into fewer U.S. dollars. For the first quarter of fiscal 2017, net sales of our U.K. operations were 3.7% of our consolidated net sales. Future impacts on our U.K. operations and financial results will depend, in part, on the outcome of tariff, trade, regulatory and other negotiations.

Commitments and Contingencies

Contractual Obligations

During the first quarter of fiscal 2017, our net borrowings on the Revolving Facility were $145.7. As noted above, on October 20, 2016, we terminated our commitments under the Netherlands Credit Facility and repaid all outstanding loans and other obligations in full, in the amount of €251.3 (approximately $277.0). As of December 31, 2016, future repayments of debt are as follows: $185.0 in fiscal 2019, $401.0 in fiscal 2020, $600.0 in fiscal 2021 and $500.0 in fiscal 2022.

There have been no other material changes in our contractual obligations since the presentation in our Annual Report on Form 10-K, as filed with the SEC on November 18, 2016.

37

Environmental Matters

Our operations, like those of other companies, are subject to various federal, state, foreign and local laws and regulations intended to protect the public health and the environment. These regulations relate primarily to worker safety, air and water quality, underground fuel storage tanks and waste handling and disposal. It is difficult to quantify with certainty the cost of environmental matters, particularly remediation and future capital expenditures for environmental control equipment. Total environmental capital expenditures and operating expenses are not expected to have a material effect on our total capital and operating expenditures, consolidated earnings or competitive position. However, current environmental spending estimates could be modified as a result of changes in our plans or our understanding of underlying facts, changes in legal requirements, including any requirements related to global climate change, or other factors.

Legal and Other Contingencies

We, and our affiliates, are subject to a number of legal proceedings in various jurisdictions arising out of our operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. We review our legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follow appropriate accounting guidance when making accrual and disclosure decisions. We establish accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and disclose the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial statements to not be misleading. We do not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, we believe that our liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to our financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices and interests rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, see Note 12 of Notes to Condensed Consolidated Financial Statements. As of December 31, 2016, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of December 31, 2016, our outstanding variable-rate debt included $401.0 million on our revolving credit facility in the U.S. and $185.0 million on our term loan. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would increase by approximately $5.9 million.

There have been no material changes in our assessment of market risk sensitivity since our presentation of "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K, as filed with the SEC on November 18, 2016.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2016. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2016 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

38

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

We, and our affiliates, are subject to a number of legal proceedings in various jurisdictions arising out of our operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. We review our legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follow appropriate accounting guidance when making accrual and disclosure decisions. We establish accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and disclose the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial statements to not be misleading. We do not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, we believe that our liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to our financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

Item 1A. Risk Factors.

There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on November 18, 2016. Refer to Item 1A. Risk Factors in our Annual Report on Form 10-K for a detailed discussion of risk factors that could materially adversely affect our business, our operating results or our financial condition.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table sets forth the purchases of the Company's securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the first quarter of fiscal 2017.

Period	Total Number of  Shares Purchased (1)(2)	Average Price Paid  per share (3)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Maximum Number that May Yet Be Purchased Under the Plans or Programs
October 1 to 31, 2016	2,850	$	74.98	2,850	5,497,925
November 1 to 30, 2016	460,422	75.63		370,142	5,127,783
December 1 to 31, 2016	385,084	78.09		385,000	4,742,783

(1) 90,364 shares purchased during the quarter relate to the surrender to the Company of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock equivalent awards.

(2) In May 2015, the Company's Board of Directors approved an authorization to repurchase up to ten million shares of the Company's common stock. This authorization replaced a prior share repurchase authorization. During the first quarter of fiscal 2017, the Company repurchased 757,992 shares under this resolution.

(3) Includes $0.02 per share of brokerage fee commissions.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

39

Item 6. Exhibits.

Exhibit Number	Exhibit
31.1	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following materials from the Edgewell Personal Care Company Quarterly Report on Form 10-Q formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Earnings and Comprehensive Income for the three months ended December 31, 2016 and 2015, (ii) the Condensed Consolidated Balance Sheets at December 31, 2016 and September 30, 2016, (iii) the Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2016 and 2015 and (iv) Notes to Condensed Consolidated Financial Statements. The financial information contained the XBRL-related documents is "unaudited" and "unreviewed."

40

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		EDGEWELL PERSONAL CARE COMPANY
		Registrant
		By:	/s/ Sandra J. Sheldon
			Sandra J. Sheldon
			Chief Financial Officer
			(on behalf of the Registrant and as principal financial officer)
Date:	February 7, 2017

41

EX-31.1

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David P. Hatfield, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Edgewell Personal Care Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 7, 2017

/s/ David P. Hatfield

David P. Hatfield

Chief Executive Officer

(principal executive officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Sandra J. Sheldon, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Edgewell Personal Care Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 7, 2017

/s/ Sandra J. Sheldon

Sandra J. Sheldon

Chief Financial Officer

(principal financial officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Edgewell Personal Care Company (the "Company") hereby certifies to his knowledge that the Company's quarterly report on Form 10-Q for the period ended December 31, 2016 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 7, 2017

/s/ David P. Hatfield

David P. Hatfield

Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Edgewell Personal Care Company (the "Company") hereby certifies to her knowledge that the Company's quarterly report on Form 10-Q for the period ended December 31, 2016 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 7, 2017

/s/ Sandra J. Sheldon

Sandra J. Sheldon

Chief Financial Officer

XML

Document and Entity Information - shares	3 Months Ended
	Dec. 31, 2016	Jan. 31, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Entity Filer Category	Large Accelerated Filer
Trading Symbol	EPC
Document Type	10-Q
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		57,419,038

XML

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Net sales	$ 485.0	$ 495.1
Cost of products sold	257.0	267.6
Gross profit	228.0	227.5
Selling, general and administrative expense	93.8	100.4
Advertising and sales promotion expense	50.6	46.6
Research and development expense	16.3	16.0
Restructuring charges	6.9	18.5
Interest expense associated with debt	17.4	17.7
Other income, net	(1.9)	(2.4)
Earnings before income taxes	44.9	30.7
Income tax provision	11.4	7.0
Net earnings	$ 33.5	$ 23.7
Basic net earnings per share (in usd per share)	$ 0.58	$ 0.40
Diluted net earnings per share (in usd per share)	$ 0.58	$ 0.39
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 33.5	$ 23.7
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	(38.7)	(10.5)
Pension and postretirement activity, net of tax	3.9	0.5
Deferred gain (loss) on hedging activity, net of tax	7.9	(1.9)
Total other comprehensive loss, net of tax	(26.9)	(11.9)
Total comprehensive income	$ 6.6	$ 11.8

XML

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Pension and postretirement activity, tax	$ 0.6	$ 0.4
Deferred gain (loss) on hedging activity, tax	$ (4.1)	$ 0.9

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2016	Sep. 30, 2016
Current assets
Cash and cash equivalents	$ 418.5	$ 738.9
Trade receivables, less allowance for doubtful accounts	228.4	260.7
Inventories	339.0	309.2
Other current assets	151.7	143.2
Total current assets	1,137.6	1,452.0
Property, plant and equipment, net	472.6	486.1
Goodwill	1,429.1	1,420.3
Other intangible assets, net	1,388.5	1,385.1
Other assets	27.4	28.0
Total assets	4,455.2	4,771.5
Current liabilities
Current maturities of long-term debt	0.0	281.8
Notes payable	18.3	18.5
Accounts payable	181.6	196.5
Other current liabilities	273.4	371.4
Total current liabilities	473.3	868.2
Long-term debt	1,680.5	1,544.2
Deferred income tax liabilities	255.8	255.3
Other liabilities	267.6	274.8
Total liabilities	2,677.2	2,942.5
Shareholders' equity
Preferred shares	0.0	0.0
Common shares	0.7	0.7
Additional paid-in capital	1,630.1	1,642.5
Retained earnings	981.1	946.0
Common shares in treasury at cost	(609.8)	(563.0)
Accumulated other comprehensive loss	(224.1)	(197.2)
Total shareholders' equity	1,778.0	1,829.0
Total liabilities and shareholders' equity	$ 4,455.2	$ 4,771.5

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2016	Sep. 30, 2016
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5.5	$ 4.9
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	57,305,242	57,914,448
Treasury shares (in shares)	7,946,747	7,337,541

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flow from Operating Activities
Net earnings	$ 33.5	$ 23.7
Non-cash restructuring costs	1.7	0.7
Depreciation and amortization	23.4	20.2
Non-cash items included in income, net	(0.5)	7.2
Share-based compensation expense	5.7	6.4
Other, net	(4.1)	(11.5)
Changes in current assets and liabilities used in operations	(118.7)	(105.4)
Net cash used by operating activities	(59.0)	(58.7)
Cash Flow from Investing Activities
Capital expenditures	(13.7)	(14.5)
Acquisitions, net of cash acquired	(34.0)	0.0
Net cash used by investing activities	(47.7)	(14.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	146.0	347.8
Cash payments on debt with original maturities greater than 90 days	(287.0)	(203.0)
Net decrease in debt with original maturities of 90 days or less	(0.4)	(2.2)
Common shares purchased	(58.0)	(78.9)
Net cash (used by) from financing activities	(199.4)	63.7
Effect of exchange rate changes on cash	(14.3)	(8.4)
Net decrease in cash and cash equivalents	(320.4)	(17.9)
Cash and cash equivalents, beginning of period	738.9	712.1
Cash and cash equivalents, end of period	$ 418.5	$ 694.2

XML

Background and Basis of Presentation

3 Months Ended

Dec. 31, 2016

Background and Basis of Presentation [Abstract]

Background and Basis of Presentation

Background and Basis of Presentation

Background

Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell" or the "Company"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. Edgewell has a portfolio of over 25 brands and a global footprint in more than 50 countries.

The Company conducts its business in the following four segments:

• Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.

• Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves.

• Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.

• All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP"), under the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 18, 2016.

Acquisition of Bulldog Skincare. On October 31, 2016, the Company completed the acquisition of Bulldog Skincare Holdings Limited ("Bulldog"), a men's grooming and skincare products company based in the United Kingdom ("U.K."). The results of Bulldog for the post-acquisition period are included within the Company's results for the three months ended December 31, 2016. For more information on the acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements.

Statement of Cash Flows Presentation. The net presentation of borrowings and repayments under the Company's U.S. revolving credit facility in the Condensed Consolidated Statement of Cash Flows for the three months ended December 31, 2015 has been revised in order to properly reflect borrowings and repayments on a gross basis, resulting in $203.0 of repayments presented gross that were previously netted against borrowings. Net cash from financing activities reported in the Condensed Consolidated Statement of Cash Flows for the three months ended December 31, 2015 was not impacted, and the Company has concluded that the correction was not material to its financial statements and that the error was not material to any other period.

Recently Issued Accounting Pronouncements. In November 2016, the Financial Accounting Standards Board ("FASB") issued an Accounting Standards Update ("ASU") which requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. These amounts should be included within cash and cash equivalents when reconciling the beginning and ending balances for the periods shown on the statement of cash flows. The ASU requires retrospective application, and will be effective for the Company beginning October 1, 2018, with early adoption permitted. The Company does not expect to early adopt this guidance and the impact on the financial statements is not expected to be material.

In January 2017, FASB issued new guidance clarifying the definition of a business, reducing the number of transactions that need to be further evaluated and providing a framework to assist entities in evaluating whether both an input and a substantive process are present. The amendments in the ASU specify that when the fair value of the gross assets acquired or disposed of is concentrated in a single identifiable asset or a group of similar identifiable assets, the integrated set of assets and activities is not a business. The guidance also requires that an integrated set of assets and activities must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output to be considered a business, and removes the evaluation of whether a market participant could replace the missing elements. The ASU will be effective for transactions occurring after October 1, 2018, with early adoption permitted.

In January 2017, FASB issued new guidance which simplifies the subsequent measurement of goodwill by eliminating step 2 from the goodwill impairment test. Under existing guidance, an entity performs procedures to determine the fair value at the impairment testing date of its assets and liabilities following the same procedures required when determining the fair value of assets acquired and liabilities assumed in a business combination. The amended guidance requires an entity to perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge to the extent the carrying amount exceeds the fair value and does not exceed the total amount of goodwill allocated to the reporting unit. The ASU will be effective for the Company beginning October 1, 2021, with early adoption permitted, and should be applied prospectively. The Company is in the process of determining what impact, if any, the new guidance will have on its annual impairment testing and whether or not it will early adopt the new guidance.

XML

Acquisition

3 Months Ended

Dec. 31, 2016

Acquisition [Abstract]

Acquisition

Acquisition

Bulldog Skincare Holdings, Limited

On October 31, 2016, the Company completed the acquisition of Bulldog, a men's grooming and skincare products company based in the U.K., for £27.8, or $34.0, net of cash acquired. The acquisition creates opportunities to expand Edgewell's personal care portfolio into a growing global category where it can leverage its international geographic footprint. The acquisition was financed through available foreign cash.

The Company has recognized the assets and liabilities of Bulldog based on preliminary estimates of their acquisition date fair values. The determination of the fair values of the acquired assets and assumed liabilities, including goodwill and other intangible assets, requires significant judgment. As of December 31, 2016, this valuation analysis was not complete, including the allocations to goodwill and other intangible assets, and the related deferred tax impacts. The Company expects to complete the final fair value determinations no later than the third quarter of fiscal 2017.

As of December 31, 2016, net assets acquired totaled $35.2 and consisted of working capital and other net assets of $4.6 (including cash of $1.2), other intangible assets of $12.8 and goodwill of $17.8, representing the value of expansion into new markets and the acquired workforce of Bulldog. Goodwill is not expected to be deductible for tax purposes. The intangible assets acquired consisted primarily of the Bulldog trade name, customer relationships and product formulations. Amortization expense for the current period was estimated using a weighted-average useful life of 13.5 years for those assets preliminarily identified as definite-lived; however, the Company is still in the process of evaluating the useful lives of the acquired intangible assets. All assets are included in the Company's Sun and Skin Care segment.

Acquisition and integration costs related to the acquisition were not material.

XML

Restructuring Charges

3 Months Ended

Dec. 31, 2016

Restructuring Charges [Abstract]

Restructuring Charges

Restructuring Charges

Spin Restructuring

The Company initiated certain restructuring activities related to the July 1, 2015 separation of its Household Products business into a separate, publicly-traded company (the "Spin") in order to prepare both businesses to operate as stand-alone entities. The restructuring activities included efforts to adapt the global go-to-market footprint to adjust to the future strategies and scale of each stand-alone business; centralize certain back-office functions to increase efficiencies; outsource certain non-core transactional activities; and reduce headcount to optimize the cost structures of each stand-alone business. As of December 31, 2016 and September 30, 2016, $2.7 and $5.2 of accrued Spin restructuring charges were included in Other current liabilities.

Restructuring

In November 2012, the Company's Board of Directors (the "Board") authorized an enterprise-wide restructuring plan (the "Restructuring"). The Restructuring originally included several initiatives focused on reducing costs in general and administrative functions, as well as reducing manufacturing and operating costs associated with the Company's discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges specific to Edgewell have primarily related to plant closure and accelerated depreciation charges and severance and related benefit costs. Project-to-date restructuring costs total $147.0. The Company now expects full year restructuring costs to total $20.0 to $25.0 for 2017, and does not currently expect costs in future periods to be material.

Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave and Feminine Care segments for the three months ended December 31, 2016 and 2015. The Company does not include restructuring costs in the results of its reportable segments.

	Three Months Ended December 31, 2016
	Wet Shave		Feminine Care		Total
Restructuring
Severance and related benefit costs	$	0.4	$	1.5	$	1.9
Asset impairment and accelerated depreciation	—		1.7		1.7
Consulting, program management and other exit costs	1.7		1.6		3.3
Total Restructuring	$	2.1	$	4.8	$	6.9

	Three Months Ended December 31, 2015
	Wet Shave		Feminine Care		Total
Restructuring
Severance and related benefit costs	$	10.5	$	3.1	$	13.6
Asset impairment and accelerated depreciation	—		0.7		0.7
Consulting, program management and other exit costs	0.7		3.5		4.2
Total Restructuring	$	11.2	$	7.3	$	18.5

In addition, pre-tax costs of $0.3 for the three months ended December 31, 2016 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring were included in Cost of products sold. There were no obsolescence charges recorded during the three months ended December 31, 2015.

The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for the first three months of fiscal 2017:

								Utilized
	October 1, 2016		Charge to Income		Other (1)			Cash			Non-Cash			December 31, 2016
Restructuring
Severance and termination related costs	$	16.7	$	1.9	$	(0.7	)	$	(2.0	)	$	—		$	15.9
Asset impairment and accelerated depreciation	—		1.7		—			—			(1.7		)	—
Other related costs	—		3.3		—			(3.3		)	—			—
Total Restructuring	$	16.7	$	6.9	$	(0.7	)	$	(5.3	)	$	(1.7	)	$	15.9

(1) Includes the impact of currency translation.

The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2016:

							Utilized
	October 1, 2015		Charge to Income		Other (1)		Cash			Non-Cash			September 30, 2016
Restructuring
Severance and termination related costs	$	13.7	$	17.0	$	0.6	$	(14.6	)	$	—		$	16.7
Asset impairment and accelerated depreciation	—		3.9		—		—			(3.9		)	—
Other related costs	—		16.1		—		(16.1		)	—			—
Total Restructuring	$	13.7	$	37.0	$	0.6	$	(30.7	)	$	(3.9	)	$	16.7

(1) Includes the impact of currency translation.

XML

Income Taxes

3 Months Ended

Dec. 31, 2016

Income Taxes [Abstract]

Income Taxes

Income Taxes

For the three months ended December 31, 2016 and 2015, the Company had income tax expense of $11.4 and $7.0, respectively, on Earnings before income taxes of $44.9 and $30.7, respectively. The effective tax rate for the three months ended December 31, 2016 was 25.4% compared to 22.8% for the three months ended December 31, 2015. The difference between the federal statutory rate and the effective rate for both periods is due to a higher mix of earnings in lower tax rate jurisdictions and was favorably impacted by Spin costs and Restructuring charges in higher tax rate jurisdictions. In addition, the effective tax rate for both periods was impacted by favorable tax adjustments, which reduced the effective rate by approximately 4%.

XML

Earnings per Share

3 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share

Basic earnings per share is based on the average number of common shares outstanding during the period. Diluted earnings per share is based on the average number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent ("RSE") awards.

Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation:

	Three Months Ended December 31,
	2016	2015
Basic weighted-average shares outstanding	57.7	59.7
Effect of dilutive securities:
Share options	—	—
RSE awards	0.4	0.2
Total dilutive securities	0.4	0.2
Diluted weighted-average shares outstanding	58.1	59.9

For the three months ended December 31, 2016, the calculation of diluted weighted-average shares outstanding excludes 0.6 of share options because the effect of including these awards was anti-dilutive. For the three months ended December 31, 2016, the number of RSE awards considered anti-dilutive was immaterial. For the three months ended December 31, 2015, the calculation of diluted weighted-average shares outstanding excludes 0.4 of share options and 0.2 of RSE awards because the effect of including these awards was anti-dilutive.

XML

Goodwill and Intangible Assets

3 Months Ended

Dec. 31, 2016

Goodwill and Intangibles [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

The following table sets forth goodwill by segment:

	Wet Shave			Sun and Skin Care		Feminine Care			All Other		Total
Balance at October 1, 2016	$	965.3		$	178.0	$	207.4		$	69.6	$	1,420.3
Acquisition of Bulldog	—			17.8		—			—		17.8
Cumulative translation adjustment	(8.0		)	—		(1.0		)	—		(9.0		)
Balance at December 31, 2016	$	957.3		$	195.8	$	206.4		$	69.6	$	1,429.1

Total amortizable intangible assets were as follows: 

	December 31, 2016						September 30, 2016
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trade names and brands	$	45.4	$	12.5	$	32.9	$	14.6	$	12.2	$	2.4
Technology and patents	77.0		70.3		6.7		76.9		69.8		7.1
Customer related and other	143.9		81.2		62.7		141.8		79.6		62.2
Total amortizable intangible assets	$	266.3	$	164.0	$	102.3	$	233.3	$	161.6	$	71.7

The preliminary estimate of amortizable intangible assets related to the Bulldog acquisition was $4.4, see Note 2 of Notes to Condensed Consolidated Financial Statements for more information. Amortization expense was $4.0 and $3.6 for the three months ended December 31, 2016 and 2015, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2017 and for fiscal 2018, 2019, 2020, 2021 and 2022 is approximately $12.0, $8.5, $7.3, $6.6, $6.0 and $5.9, respectively, and $56.0 thereafter.

The Company had indefinite-lived intangible assets of $1,286.2 ($223.0 in Wet Shave, $499.8 in Sun and Skin Care, $299.9 in Feminine Care and $263.5 in All Other) at December 31, 2016, a decrease of $27.2 from September 30, 2016. Indefinite-lived intangible assets decreased $30.9 due to the conversion of the Skintimate® brand name to a definite-lived intangible asset, as noted below, and changes in foreign currency translation rates. The preliminary estimate of indefinite-lived intangible assets related to the Bulldog acquisition was $8.4; however, the Company is still in the process of determining the useful lives of the acquired intangible assets. See Note 2 of Notes to Condensed Consolidated Financial Statements for more information on the Bulldog acquisition.

Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. The Company continuously monitors changing business conditions, which may indicate that the remaining useful life of goodwill and other intangible assets may warrant revision or carrying amounts may require adjustment. During fiscal 2016 and 2015, the Company recorded impairment charges of $6.5 and $29.6, respectively, on its Skintimate® brand name, which were primarily related to the introduction of competing products in the market, resulting in share and margin declines. Based on the impairments taken in the past two years and continued competitive pressure on this brand, as of October 1, 2016 the Skintimate® brand name was converted to a definite-lived asset and assigned a useful life of 20 years. This conversion to a definite-lived intangible asset increased amortization expense by $0.4 for the three months ended December 31, 2016. During fiscal 2015, the Company also recorded impairment charges related to its Playtex® and Wet Ones® brand names. As such, the fair value of both brand names continues to be relatively close to the carrying value and these assets will continue to be sensitive in the future to changes in forecasted cash flows, as well as other assumptions used in an impairment analysis, including discount rates.

XML

Supplemental Balance Sheet Information

3 Months Ended

Dec. 31, 2016

Supplemental Financial Statement Information [Abstract]

Supplemental Balance Sheet Information

Supplemental Balance Sheet Information

	December 31, 2016			September 30, 2016
Inventories
Raw materials and supplies	$	54.0		$	50.8
Work in process	50.3			43.9
Finished products	234.7			214.5
Total inventories	$	339.0		$	309.2
Other Current Assets
Miscellaneous receivables	$	40.9		$	29.1
Prepaid expenses	53.2			49.0
Value added tax collectible from customers	23.9			22.4
Income taxes receivable	25.2			39.3
Other	8.5			3.4
Total other current assets	$	151.7		$	143.2
Property, Plant and Equipment
Land	$	27.2		$	27.8
Buildings	141.6			146.0
Machinery and equipment	904.7			913.7
Capitalized software costs	38.0			38.4
Construction in progress	43.2			36.2
Total gross property	1,154.7			1,162.1
Accumulated depreciation	(682.1		)	(676.0		)
Total property, plant and equipment, net	$	472.6		$	486.1
Other Current Liabilities
Accrued advertising, sales promotion and allowances	$	44.3		$	46.8
Accrued trade allowances	24.4			30.1
Accrued salaries, vacations and incentive compensation	26.4			56.0
Income taxes payable	11.9			19.7
Returns reserve	27.4			49.9
Restructuring reserve	18.6			21.9
Value added tax payable	25.6			25.0
Deferred compensation	26.7			26.1
Other	68.1			95.9
Total other current liabilities	$	273.4		$	371.4
Other Liabilities
Pensions and other retirement benefits	$	150.0		$	154.9
Deferred compensation	57.8			58.6
Other non-current liabilities	59.8			61.3
Total other liabilities	$	267.6		$	274.8

XML

Debt

3 Months Ended

Dec. 31, 2016

Debt [Abstract]

Debt

Debt

The detail of long-term debt was as follows:

	December 31, 2016		September 30, 2016
Senior notes, fixed interest rate of 4.7%, due 2021, net (1)	$	597.9	$	597.8
Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2)	497.0		496.9
U.S. revolving credit facility due 2020	401.0		265.0
Netherlands revolving credit facility due 2017	—		281.8
Term loan, due 2019, net (1)	184.6		184.5
Total long-term debt, including current maturities	1,680.5		1,826.0
Less current portion	—		281.8
Total long-term debt	$	1,680.5	$	1,544.2

(1) At December 31, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.1, $2.2 and $0.4, respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2, $2.3 and $0.5, respectively.

(2) At December 31, 2016 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.8.

The Company had outstanding international borrowings, recorded in Notes payable, of $18.3 and $18.5as of December 31, 2016 and September 30, 2016, respectively.

Netherlands Revolving Credit Facility

On October 20, 2016, the Company terminated its commitments under the Netherlands revolving credit facility and repaid all outstanding loans and other obligations in full, in the amount of €251.3, or approximately $277.0.

XML

Retirement Plans

3 Months Ended

Dec. 31, 2016

Pension and Other Postretirement Benefits [Abstract]

Retirement Plans

Retirement Plans

The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below.

The Company's net periodic pension benefit (credit) cost for these plans was as follows: 

	Three Months Ended December 31,
	2016			2015
Service cost	$	1.8		$	1.3
Interest cost	3.8			5.5
Expected return on plan assets	(7.9		)	(6.9		)
Amortization of unrecognized prior service cost	—			—
Recognized net actuarial loss	1.5			1.0
Settlement loss recognized	0.3			—
Net periodic benefit (credit) cost	$	(0.5	)	$	0.9

In fiscal 2017, the Company changed the methodology used to estimate the service and interest components of net periodic benefit (credit) cost for its pension benefits, which will result in a decrease in expense of approximately $4 during fiscal 2017. The Company believes the spot discount rate approach, which applies the specific spot rates along the yield curve used in the determination of the benefit obligations to the relevant cash flows, is a more precise application of the yield curve spot rates used in the traditional single discount rate approach. The change was accounted for prospectively as a change in accounting estimate.

XML

Shareholders' Equity

3 Months Ended

Dec. 31, 2016

Shareholders' Equity [Abstract]

Shareholders' Equity

Shareholders' Equity

In May 2015, the Board approved an authorization to repurchase up to 10.0 shares of the Company's common stock. This authorization replaced a prior share repurchase authorization. During the three months ended December 31, 2016, the Company repurchased 0.8 shares of its common stock for $58.0, all of which were purchased under this authorization. The Company has 4.7 shares remaining under the Board authorization to repurchase its common shares in the future. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors.

During the three months ended December 31, 2016, 0.1 shares were purchased related to the surrender of shares of common stock to satisfy tax withholding obligations in connection with the vesting of RSE awards.

During the three months ended December 31, 2016, the Company paid $0.8 cash dividends related to the vesting of RSE awards, which had been declared and accrued during prior fiscal years. The Company has not declared any dividends since the third quarter of fiscal 2015, and does not currently intend to declare dividends in the foreseeable future.

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Dec. 31, 2016

Accumulated Other Comprehensive (Loss) Income [Abstract]

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component:

	Foreign Currency Translation Adjustments			Pension and Post-retirement Activity			Hedging Activity			Total
Balance at October 1, 2016	$	(68.1	)	$	(126.3	)	$	(2.8	)	$	(197.2	)
OCI before reclassifications (1)	(38.7		)	2.7			8.1			(27.9		)
Reclassifications to earnings	—			1.2			(0.2		)	1.0
Balance at December 31, 2016	$	(106.8	)	$	(122.4	)	$	5.1		$	(224.1	)

	Foreign Currency Translation Adjustments			Pension and Post-retirement Activity			Hedging Activity			Total
Balance at October 1, 2015	$	(69.1	)	$	(105.7	)	$	3.3		$	(171.5	)
OCI before reclassifications (1)	(10.5		)	(0.1		)	(4.4		)	(15.0		)
Reclassifications to earnings	—			0.6			2.5			3.1
Balance at December 31, 2015	$	(79.6	)	$	(105.2	)	$	1.4		$	(183.4	)

(1) OCI is defined as other comprehensive income (loss).

The following table presents the reclassifications out of AOCI:

	For the Three Months Ended December 31,						Affected Line Item in the Condensed Consolidated Statements of Earnings
Details of AOCI Components	2016			2015
Gains and losses on cash flow hedges
Foreign exchange contracts	$	(0.3	)	$	3.6		Other income, net
	(0.3		)	3.6			Total before tax
	0.1			(1.1		)	Tax expense
	$	(0.2	)	$	2.5		Net of tax
Amortization of defined benefit pension and postretirement items
Prior service costs	$	—		$	—		(1)
Actuarial losses	1.5			1.0			(1)
Settlement loss recognized	0.3			—			(1)
	1.8			1.0			Total before tax
	(0.6		)	(0.4		)	Tax expense
	$	1.2		$	0.6		Net of tax
Total reclassifications for the period	$	1.0		$	3.1		Net of tax

(1) These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

XML

Financial Instruments and Risk Management

3 Months Ended

Dec. 31, 2016

Financial Instruments and Risk Management [Abstract]

Financial Instruments and Risk Management

Financial Instruments and Risk Management

At times, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and interest rate risks. The section below outlines the types of derivatives that existed at December 31, 2016 and September 30, 2016, as well as the Company's objectives and strategies for holding derivative instruments.

Foreign Currency Risk

A significant share of the Company's sales are tied to currencies other than the U.S. dollar, the Company's reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact to reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the Euro, the Japanese Yen, the British Pound, the Canadian Dollar and the Australian Dollar.

Additionally, the Company's foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary's local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary's local currency results in an exchange gain or loss recorded in Other income, net. The primary currency to which the Company's foreign subsidiaries are exposed is the U.S. dollar.

Interest Rate Risk

The Company has interest rate risk with respect to interest expense on variable rate debt. At December 31, 2016, the Company had $585.6 of variable rate debt outstanding, which consisted of outstanding borrowings under the Company's revolving credit facility in the U.S. and term loan.

Cash Flow Hedges

At December 31, 2016, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective for accounting purposes in offsetting the associated risk.

The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $7.7 at December 31, 2016 compared to an unrealized loss of $4.3 at September 30, 2016 on these forward currency contracts accounted for as cash flow hedges included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at December 31, 2016 levels over the next twelve months, approximately $7.4 of the pre-tax loss included in AOCI at December 31, 2016 is expected to be included in Other income, net. Contract maturities for these hedges extend into fiscal 2018. There were 72 open foreign currency contracts at December 31, 2016 with a total notional value of $132.0.

Derivatives not Designated as Hedges

The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures, thus they are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three months ended December 31, 2016 resulted in a gain of $2.6 and was recorded in Other income, net. The change in estimated fair value of the foreign currency contracts for the three months ended December 31, 2015 was immaterial. There were five open foreign currency derivative contracts, which were not designated as cash flow hedges at December 31, 2016, with a total notional value of $84.8.

The following table provides estimated fair values and the amounts of gains and losses on derivative instruments classified as cash flow hedges:

	At December 31, 2016			For the Three Months Ended December 31, 2016
Derivatives designated as cash flow hedging relationships	Estimated Fair Value, Asset (1) (2)			Gain Recognized in OCI		Loss Reclassified From OCI into Income (Effective Portion) (3) (4)
Foreign currency contracts	$	7.7		$	11.7	$	(0.3	)
	At September 30, 2016			For the Three Months Ended December 31, 2015
Derivatives designated as cash flow hedging relationships	Estimated Fair Value, Liability (1) (2)			Gain Recognized in OCI		Gain Reclassified From OCI into Income (Effective Portion) (3) (4)
Foreign currency contracts	$	(4.3	)	$	0.8	$	3.6

(1) All derivative assets are presented in Other current assets or Other assets.

(2) All derivative liabilities are presented in Other current liabilities or Other liabilities.

(3) (Loss) gain reclassified to income was recorded in Other income, net.

(4) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.

The following table provides estimated fair values and the amounts of gains and losses on derivative instruments not classified as cash flow hedges:

	At December 31, 2016			For the Three Months Ended December 31, 2016
Derivatives not designated as cash flow hedging relationships	Estimated Fair Value, Asset			Gain Recognized in Income (1)
Foreign currency contracts	$	2.8		$	2.6
	At September 30, 2016			For the Three Months Ended December 31, 2015
Derivatives not designated as cash flow hedging relationships	Estimated Fair Value, Liability			Gain Recognized in Income (1)
Foreign currency contracts	$	(1.3	)	$	—

(1) Gain recognized in income was recorded in Other income, net.

The following table provides financial assets and liabilities for balance sheet offsetting:

Offsetting of derivative assets
		At December 31, 2016									At September 30, 2016
Description	Balance Sheet location	Gross amounts of recognized assets			Gross amounts offset in the Balance Sheet			Net amounts of assets presented in the Balance Sheet			Gross amounts of recognized assets			Gross amounts offset in the Balance Sheet		Net amounts of assets presented in the Balance Sheet
Foreign currency contracts	Other current assets, Other assets	$	11.9		$	(0.5	)	$	11.4		$	1.7		$	—	$	1.7
Offsetting of derivative liabilities
		At December 31, 2016									At September 30, 2016
Description	Balance Sheet location	Gross amounts of recognized liabilities			Gross amounts offset in the Balance Sheet			Net amounts of liabilities presented in the Balance Sheet			Gross amounts of recognized liabilities			Gross amounts offset in the Balance Sheet		Net amounts of liabilities presented in the Balance Sheet
Foreign currency contracts	Other current liabilities, Other liabilities	$	(0.9	)	$	—		$	(0.9	)	$	(6.2	)	$	0.2	$	(6.0	)

Fair Value Hierarchy

Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets.

Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy:

	December 31, 2016			September 30, 2016
Assets (Liabilities) at estimated fair value:
Deferred compensation	$	(84.3	)	$	(84.5	)
Derivatives - foreign currency contracts	10.5			(5.6		)
Net liabilities at estimated fair value	$	(73.8	)	$	(90.1	)

At December 31, 2016 and September 30, 2016, the Company had no level 1 or level 3 financial assets or liabilities, other than pension plan assets.

At December 31, 2016 and September 30, 2016, the fair market value of fixed rate long-term debt was $1,126.3 and $1,106.2, respectively, compared to its carrying value of $1,094.9 and $1,094.7, respectively. The estimated fair value of the long-term debt is estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of variable-rate debt, excluding revolving credit facilities, which consists of bank debt, was $185.0 compared to its carrying value of $184.6 and $184.5 at December 31, 2016 and September 30, 2016, respectively. The estimated fair value is equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on level 2 inputs.

Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company's revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings and the revolving credit agreements have been determined based on level 2 inputs.

At December 31, 2016, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan.

XML

Commitments and Contingencies

3 Months Ended

Dec. 31, 2016

Legal Proceedings and Contingencies [Abstract]

Commitments and Contingencies

Commitments and Contingencies

The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, if the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to the Company's financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

XML

Segment Data

3 Months Ended

Dec. 31, 2016

Segments [Abstract]

Segment Data

Segment Data

The Company conducts its business in the following four segments:

• Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.

• Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves.

• Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.

• All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.

Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.

The Company's operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and in most cases a combined sales force and management teams. The Company applies a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis.

Segment net sales and profitability are presented below:

	Three Months Ended December 31,
	2016			2015
Net Sales
Wet Shave	$	306.2		$	316.3
Sun and Skin Care	57.6			53.5
Feminine Care	89.1			92.5
All Other	32.1			32.8
Total net sales	$	485.0		$	495.1
Segment Profit
Wet Shave	$	72.0		$	66.8
Sun and Skin Care	0.8			1.7
Feminine Care	8.3			17.6
All Other	6.9			7.2
Total segment profit	88.0			93.3
General corporate and other expenses	(16.4		)	(17.7		)
Spin costs (1)	—			(7.5		)
Restructuring and related costs (2)	(7.2		)	(18.5		)
Amortization of intangibles	(4.0		)	(3.6		)
Interest and other expense, net	(15.5		)	(15.3		)
Total earnings before income taxes	$	44.9		$	30.7

(1) Includes pre-tax Selling, general and administrative expense of $7.3 and pre-tax Cost of products sold of $0.2 for the three months ended December 31, 2015 related to the separation of the Household Products business in July 2015.

(2) Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the three months ended December 31, 2016.

Supplemental product information is presented below for net sales:

	Three Months Ended December 31,
	2016		2015
Razors and blades	$	271.3	$	274.2
Tampons, pads and liners	89.1		92.5
Sun care products	37.7		36.9
Infant care and other	32.1		32.7
Shaving gels and creams	34.9		42.2
Skin care products	19.9		16.6
Total net sales	$	485.0	$	495.1

XML

Guarantor and Non-Guarantor Financial Information

3 Months Ended

Dec. 31, 2016

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

Guarantor and Non-Guarantor Financial Information

The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture.

Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of the Parent Company, Edgewell Personal Care Company, the Guarantors on a combined basis, the Non-Guarantors on a combined basis and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors.

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

Three Months Ended December 31, 2016

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	342.9		$	232.3		$	(90.2	)	$	485.0
Cost of products sold	—			204.5			142.7			(90.2		)	257.0
Gross profit	—			138.4			89.6			—			228.0
Selling, general and administrative expense	—			58.7			35.1			—			93.8
Advertising and sales promotion expense	—			30.2			20.4			—			50.6
Research and development expense	—			16.0			0.3			—			16.3
Restructuring charges	—			2.7			4.2			—			6.9
Interest expense associated with debt	13.4			3.3			0.7			—			17.4
Other expense (income), net	—			0.4			(2.3		)	—			(1.9		)
Intercompany service fees	—			(4.4		)	4.4			—			—
Equity in earnings of subsidiaries	(41.9		)	(21.1		)	—			63.0			—
Earnings before income taxes	28.5			52.6			26.8			(63.0		)	44.9
Income tax (benefit) provision	(5.0		)	10.9			5.5			—			11.4
Net earnings	$	33.5		$	41.7		$	21.3		$	(63.0	)	$	33.5
Statement of Comprehensive Income:
Net earnings	$	33.5		$	41.7		$	21.3		$	(63.0	)	$	33.5
Other comprehensive loss, net of tax	(26.9		)	(3.2		)	(27.8		)	31.0			(26.9		)
Total comprehensive income	$	6.6		$	38.5		$	(6.5	)	$	(32.0	)	$	6.6

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

Three Months Ended December 31, 2015

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	336.8		$	269.5		$	(111.2	)	$	495.1
Cost of products sold	—			204.9			174.8			(112.1		)	267.6
Gross profit	—			131.9			94.7			0.9			227.5
Selling, general and administrative expense	3.1			60.7			36.6			—			100.4
Advertising and sales promotion expense	—			27.5			19.2			(0.1		)	46.6
Research and development expense	—			15.6			0.4			—			16.0
Restructuring charges	—			4.7			13.8			—			18.5
Interest expense associated with debt	16.2			—			1.5			—			17.7
Other income, net	—			(2.4		)	—			—			(2.4		)
Intercompany service fees	—			(5.5		)	5.5			—			—
Equity in earnings of subsidiaries	(35.8		)	(12.4		)	—			48.2			—
Earnings before income taxes	16.5			43.7			17.7			(47.2		)	30.7
Income tax (benefit) provision	(7.2		)	10.0			3.2			1.0			7.0
Net earnings	$	23.7		$	33.7		$	14.5		$	(48.2	)	$	23.7
Statement of Comprehensive Income:
Net earnings	23.7			33.7			14.5			(48.2		)	23.7
Other comprehensive loss, net of tax	(11.9		)	(1.9		)	(11.5		)	13.4			(11.9		)
Total comprehensive income	$	11.8		$	31.8		$	3.0		$	(34.8	)	$	11.8

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING BALANCE SHEETS

December 31, 2016

	Parent Company		Guarantors		Non-Guarantors		Eliminations			Total
Assets
Current assets
Cash and cash equivalents	$	—	$	5.1	$	413.4	$	—		$	418.5
Trade receivables, net	—		102.2		126.2		—			228.4
Inventories	—		210.8		128.2		—			339.0
Other current assets	—		41.8		109.9		—			151.7
Total current assets	—		359.9		777.7		—			1,137.6
Investment in subsidiaries	3,500.2		841.9		—		(4,342.1		)	—
Intercompany receivables, net (1)	—		579.0		42.7		(621.7		)	—
Intercompany notes receivable (1)	—		1.9		—		(1.9		)	—
Property, plant and equipment, net	—		341.8		130.8		—			472.6
Goodwill	—		1,061.9		367.2		—			1,429.1
Other intangible assets, net	—		1,231.5		157.0		—			1,388.5
Other assets	1.8		0.2		25.4		—			27.4
Total assets	$	3,502.0	$	4,418.1	$	1,500.8	$	(4,965.7	)	$	4,455.2
Liabilities and Shareholders' Equity
Current liabilities	$	7.8	$	236.3	$	229.2	$	—		$	473.3
Intercompany payables, net (1)	621.7		—		—		(621.7		)	—
Intercompany notes payable (1)	—		—		1.9		(1.9		)	—
Long-term debt	1,094.5		586.0		—		—			1,680.5
Deferred income tax liabilities	—		229.7		26.1		—			255.8
Other liabilities	—		231.6		36.0		—			267.6
Total liabilities	1,724.0		1,283.6		293.2		(623.6		)	2,677.2
Total shareholders' equity	1,778.0		3,134.5		1,207.6		(4,342.1		)	1,778.0
Total liabilities and shareholders' equity	$	3,502.0	$	4,418.1	$	1,500.8	$	(4,965.7	)	$	4,455.2

(1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING BALANCE SHEETS

September 30, 2016

	Parent Company		Guarantors		Non-Guarantors		Eliminations			Total
Assets
Current assets
Cash and cash equivalents	$	—	$	5.8	$	733.1	$	—		$	738.9
Trade receivables, net	—		108.9		151.8		—			260.7
Inventories	—		187.7		121.5		—			309.2
Other current assets	—		43.7		99.5		—			143.2
Total current assets	—		346.1		1,105.9		—			1,452.0
Investment in subsidiaries	3,483.7		825.0		—		(4,308.7		)	—
Intercompany receivables, net (1)	—		487.6		53.5		(541.1		)	—
Intercompany notes receivable (1)	—		1.9		—		(1.9		)	—
Property, plant and equipment, net	—		343.8		142.3		—			486.1
Goodwill	—		1,061.9		358.4		—			1,420.3
Other intangible assets, net	—		1,235.1		150.0		—			1,385.1
Other assets	2.0		0.1		25.9		—			28.0
Total assets	$	3,485.7	$	4,301.5	$	1,836.0	$	(4,851.7	)	$	4,771.5
Liabilities and Shareholders' Equity
Current liabilities	$	21.4	$	288.4	$	558.4	$	—		$	868.2
Intercompany payables, net (1)	541.1		—		—		(541.1		)	—
Intercompany notes payable (1)	—		—		1.9		(1.9		)	—
Long-term debt	1,094.2		450.0		—		—			1,544.2
Deferred income tax liabilities	—		232.4		22.9		—			255.3
Other liabilities	—		236.3		38.5		—			274.8
Total liabilities	1,656.7		1,207.1		621.7		(543.0		)	2,942.5
Total shareholders' equity	1,829.0		3,094.4		1,214.3		(4,308.7		)	1,829.0
Total liabilities and shareholders' equity	$	3,485.7	$	4,301.5	$	1,836.0	$	(4,851.7	)	$	4,771.5

(1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Three Months Ended December 31, 2016

	Parent Company			Guarantors			Non-Guarantors			Eliminations		Total
Net cash flow from (used by) operations	$	58.0		$	(124.8	)	$	7.8		$	—	$	(59.0	)
Cash Flow from Investing Activities
Capital expenditures	—			(11.0		)	(2.7		)	—		(13.7		)
Acquisitions, net of cash acquired	—			—			(34.0		)	—		(34.0		)
Net cash used by investing activities	—			(11.0		)	(36.7		)	—		(47.7		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	—			146.0			—			—		146.0
Cash payments on debt with original maturities greater than 90 days	—			(10.0		)	(277.0		)	—		(287.0		)
Net (decrease) increase in debt with original maturities of 90 days or less	—			(0.9		)	0.5			—		(0.4		)
Common shares purchased	(58.0		)	—			—			—		(58.0		)
Net cash (used by) from financing activities	(58.0		)	135.1			(276.5		)	—		(199.4		)
Effect of exchange rate changes on cash	—			—			(14.3		)	—		(14.3		)
Net decrease in cash and cash equivalents	—			(0.7		)	(319.7		)	—		(320.4		)
Cash and cash equivalents, beginning of period	—			5.8			733.1			—		738.9
Cash and cash equivalents, end of period	$	—		$	5.1		$	413.4		$	—	$	418.5

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Three Months Ended December 31, 2015

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net cash flow from (used by) operations	$	78.9		$	(123.7	)	$	(13.9	)	$	—		$	(58.7	)
Cash Flow from Investing Activities
Capital expenditures	—			(13.0		)	(1.5		)	—			(14.5		)
Payment for equity contributions	—			(0.2		)	—			0.2			—
Net cash used by investing activities	—			(13.2		)	(1.5		)	0.2			(14.5		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	—			345.0			2.8			—			347.8
Cash payments on debt with original maturities greater than 90 days	—			(203.0		)	—			—			(203.0		)
Net (decrease) increase in debt with original maturities of 90 days or less	—			(2.4		)	0.2			—			(2.2		)
Common shares purchased	(78.9		)	—			—			—			(78.9		)
Proceeds for equity contributions	—			—			0.2			(0.2		)	—
Net cash (used by) from financing activities	(78.9		)	139.6			3.2			(0.2		)	63.7
Effect of exchange rate changes on cash	—			—			(8.4		)	—			(8.4		)
Net increase (decrease) in cash and cash equivalents	—			2.7			(20.6		)	—			(17.9		)
Cash and cash equivalents, beginning of period	—			2.9			709.2			—			712.1
Cash and cash equivalents, end of period	$	—		$	5.6		$	688.6		$	—		$	694.2

XML

Restructuring Charges (Tables)

3 Months Ended

Dec. 31, 2016

Restructuring Charges [Abstract]

Schedule of Charges Related to Restructuring Activities

Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave and Feminine Care segments for the three months ended December 31, 2016 and 2015. The Company does not include restructuring costs in the results of its reportable segments.

	Three Months Ended December 31, 2016
	Wet Shave		Feminine Care		Total
Restructuring
Severance and related benefit costs	$	0.4	$	1.5	$	1.9
Asset impairment and accelerated depreciation	—		1.7		1.7
Consulting, program management and other exit costs	1.7		1.6		3.3
Total Restructuring	$	2.1	$	4.8	$	6.9

	Three Months Ended December 31, 2015
	Wet Shave		Feminine Care		Total
Restructuring
Severance and related benefit costs	$	10.5	$	3.1	$	13.6
Asset impairment and accelerated depreciation	—		0.7		0.7
Consulting, program management and other exit costs	0.7		3.5		4.2
Total Restructuring	$	11.2	$	7.3	$	18.5

Schedule of Restructuring Activities and Related Accruals

The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for the first three months of fiscal 2017:

								Utilized
	October 1, 2016		Charge to Income		Other (1)			Cash			Non-Cash			December 31, 2016
Restructuring
Severance and termination related costs	$	16.7	$	1.9	$	(0.7	)	$	(2.0	)	$	—		$	15.9
Asset impairment and accelerated depreciation	—		1.7		—			—			(1.7		)	—
Other related costs	—		3.3		—			(3.3		)	—			—
Total Restructuring	$	16.7	$	6.9	$	(0.7	)	$	(5.3	)	$	(1.7	)	$	15.9

(1) Includes the impact of currency translation.

The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2016:

							Utilized
	October 1, 2015		Charge to Income		Other (1)		Cash			Non-Cash			September 30, 2016
Restructuring
Severance and termination related costs	$	13.7	$	17.0	$	0.6	$	(14.6	)	$	—		$	16.7
Asset impairment and accelerated depreciation	—		3.9		—		—			(3.9		)	—
Other related costs	—		16.1		—		(16.1		)	—			—
Total Restructuring	$	13.7	$	37.0	$	0.6	$	(30.7	)	$	(3.9	)	$	16.7

(1) Includes the impact of currency translation.

XML

Earnings per Share (Tables)

3 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Schedule of Earnings per Share

Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation:

	Three Months Ended December 31,
	2016	2015
Basic weighted-average shares outstanding	57.7	59.7
Effect of dilutive securities:
Share options	—	—
RSE awards	0.4	0.2
Total dilutive securities	0.4	0.2
Diluted weighted-average shares outstanding	58.1	59.9

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Dec. 31, 2016

Goodwill and Intangibles [Abstract]

Schedule of Goodwill

The following table sets forth goodwill by segment:

	Wet Shave			Sun and Skin Care		Feminine Care			All Other		Total
Balance at October 1, 2016	$	965.3		$	178.0	$	207.4		$	69.6	$	1,420.3
Acquisition of Bulldog	—			17.8		—			—		17.8
Cumulative translation adjustment	(8.0		)	—		(1.0		)	—		(9.0		)
Balance at December 31, 2016	$	957.3		$	195.8	$	206.4		$	69.6	$	1,429.1

Schedule of Amortizable Intangible Assets

Total amortizable intangible assets were as follows: 

	December 31, 2016						September 30, 2016
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trade names and brands	$	45.4	$	12.5	$	32.9	$	14.6	$	12.2	$	2.4
Technology and patents	77.0		70.3		6.7		76.9		69.8		7.1
Customer related and other	143.9		81.2		62.7		141.8		79.6		62.2
Total amortizable intangible assets	$	266.3	$	164.0	$	102.3	$	233.3	$	161.6	$	71.7

XML

Supplemental Balance Sheet Information (Tables)

3 Months Ended

Dec. 31, 2016

Supplemental Financial Statement Information [Abstract]

Supplement Balance Sheet Information

	December 31, 2016			September 30, 2016
Inventories
Raw materials and supplies	$	54.0		$	50.8
Work in process	50.3			43.9
Finished products	234.7			214.5
Total inventories	$	339.0		$	309.2
Other Current Assets
Miscellaneous receivables	$	40.9		$	29.1
Prepaid expenses	53.2			49.0
Value added tax collectible from customers	23.9			22.4
Income taxes receivable	25.2			39.3
Other	8.5			3.4
Total other current assets	$	151.7		$	143.2
Property, Plant and Equipment
Land	$	27.2		$	27.8
Buildings	141.6			146.0
Machinery and equipment	904.7			913.7
Capitalized software costs	38.0			38.4
Construction in progress	43.2			36.2
Total gross property	1,154.7			1,162.1
Accumulated depreciation	(682.1		)	(676.0		)
Total property, plant and equipment, net	$	472.6		$	486.1
Other Current Liabilities
Accrued advertising, sales promotion and allowances	$	44.3		$	46.8
Accrued trade allowances	24.4			30.1
Accrued salaries, vacations and incentive compensation	26.4			56.0
Income taxes payable	11.9			19.7
Returns reserve	27.4			49.9
Restructuring reserve	18.6			21.9
Value added tax payable	25.6			25.0
Deferred compensation	26.7			26.1
Other	68.1			95.9
Total other current liabilities	$	273.4		$	371.4
Other Liabilities
Pensions and other retirement benefits	$	150.0		$	154.9
Deferred compensation	57.8			58.6
Other non-current liabilities	59.8			61.3
Total other liabilities	$	267.6		$	274.8

XML

Debt (Tables)

3 Months Ended

Dec. 31, 2016

Debt [Abstract]

Schedule of Long-term Debt

The detail of long-term debt was as follows:

	December 31, 2016		September 30, 2016
Senior notes, fixed interest rate of 4.7%, due 2021, net (1)	$	597.9	$	597.8
Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2)	497.0		496.9
U.S. revolving credit facility due 2020	401.0		265.0
Netherlands revolving credit facility due 2017	—		281.8
Term loan, due 2019, net (1)	184.6		184.5
Total long-term debt, including current maturities	1,680.5		1,826.0
Less current portion	—		281.8
Total long-term debt	$	1,680.5	$	1,544.2

(1) At December 31, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.1, $2.2 and $0.4, respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2, $2.3 and $0.5, respectively.

(2) At December 31, 2016 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.8.

XML

Retirement Plans (Tables)

3 Months Ended

Dec. 31, 2016

Pension and Other Postretirement Benefits [Abstract]

Schedule of Net Periodic Pension Benefit (Credit) Cost

The Company's net periodic pension benefit (credit) cost for these plans was as follows: 

	Three Months Ended December 31,
	2016			2015
Service cost	$	1.8		$	1.3
Interest cost	3.8			5.5
Expected return on plan assets	(7.9		)	(6.9		)
Amortization of unrecognized prior service cost	—			—
Recognized net actuarial loss	1.5			1.0
Settlement loss recognized	0.3			—
Net periodic benefit (credit) cost	$	(0.5	)	$	0.9

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Dec. 31, 2016

Accumulated Other Comprehensive (Loss) Income [Abstract]

Schedule of Accumulated Other Comprehensive Loss

The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component:

	Foreign Currency Translation Adjustments			Pension and Post-retirement Activity			Hedging Activity			Total
Balance at October 1, 2016	$	(68.1	)	$	(126.3	)	$	(2.8	)	$	(197.2	)
OCI before reclassifications (1)	(38.7		)	2.7			8.1			(27.9		)
Reclassifications to earnings	—			1.2			(0.2		)	1.0
Balance at December 31, 2016	$	(106.8	)	$	(122.4	)	$	5.1		$	(224.1	)

	Foreign Currency Translation Adjustments			Pension and Post-retirement Activity			Hedging Activity			Total
Balance at October 1, 2015	$	(69.1	)	$	(105.7	)	$	3.3		$	(171.5	)
OCI before reclassifications (1)	(10.5		)	(0.1		)	(4.4		)	(15.0		)
Reclassifications to earnings	—			0.6			2.5			3.1
Balance at December 31, 2015	$	(79.6	)	$	(105.2	)	$	1.4		$	(183.4	)

(1) OCI is defined as other comprehensive income (loss).

Schedule of Reclassifications out of Accumulated Other Comprehensive Loss

The following table presents the reclassifications out of AOCI:

	For the Three Months Ended December 31,						Affected Line Item in the Condensed Consolidated Statements of Earnings
Details of AOCI Components	2016			2015
Gains and losses on cash flow hedges
Foreign exchange contracts	$	(0.3	)	$	3.6		Other income, net
	(0.3		)	3.6			Total before tax
	0.1			(1.1		)	Tax expense
	$	(0.2	)	$	2.5		Net of tax
Amortization of defined benefit pension and postretirement items
Prior service costs	$	—		$	—		(1)
Actuarial losses	1.5			1.0			(1)
Settlement loss recognized	0.3			—			(1)
	1.8			1.0			Total before tax
	(0.6		)	(0.4		)	Tax expense
	$	1.2		$	0.6		Net of tax
Total reclassifications for the period	$	1.0		$	3.1		Net of tax

(1) These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

XML

Financial Instruments and Risk Management (Tables)

3 Months Ended

Dec. 31, 2016

Financial Instruments and Risk Management [Abstract]

Schedule of Derivative Instruments Designated as Cash Flow Hedges

The following table provides estimated fair values and the amounts of gains and losses on derivative instruments classified as cash flow hedges:

	At December 31, 2016			For the Three Months Ended December 31, 2016
Derivatives designated as cash flow hedging relationships	Estimated Fair Value, Asset (1) (2)			Gain Recognized in OCI		Loss Reclassified From OCI into Income (Effective Portion) (3) (4)
Foreign currency contracts	$	7.7		$	11.7	$	(0.3	)
	At September 30, 2016			For the Three Months Ended December 31, 2015
Derivatives designated as cash flow hedging relationships	Estimated Fair Value, Liability (1) (2)			Gain Recognized in OCI		Gain Reclassified From OCI into Income (Effective Portion) (3) (4)
Foreign currency contracts	$	(4.3	)	$	0.8	$	3.6

(1) All derivative assets are presented in Other current assets or Other assets.

(2) All derivative liabilities are presented in Other current liabilities or Other liabilities.

(3) (Loss) gain reclassified to income was recorded in Other income, net.

(4) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.

Schedule of Derivative Instruments Not Designated as Cash Flow Hedges

The following table provides estimated fair values and the amounts of gains and losses on derivative instruments not classified as cash flow hedges:

	At December 31, 2016			For the Three Months Ended December 31, 2016
Derivatives not designated as cash flow hedging relationships	Estimated Fair Value, Asset			Gain Recognized in Income (1)
Foreign currency contracts	$	2.8		$	2.6
	At September 30, 2016			For the Three Months Ended December 31, 2015
Derivatives not designated as cash flow hedging relationships	Estimated Fair Value, Liability			Gain Recognized in Income (1)
Foreign currency contracts	$	(1.3	)	$	—

(1) Gain recognized in income was recorded in Other income, net.

Schedule of Offsetting Assets and Liabilities

The following table provides financial assets and liabilities for balance sheet offsetting:

Offsetting of derivative assets
		At December 31, 2016									At September 30, 2016
Description	Balance Sheet location	Gross amounts of recognized assets			Gross amounts offset in the Balance Sheet			Net amounts of assets presented in the Balance Sheet			Gross amounts of recognized assets			Gross amounts offset in the Balance Sheet		Net amounts of assets presented in the Balance Sheet
Foreign currency contracts	Other current assets, Other assets	$	11.9		$	(0.5	)	$	11.4		$	1.7		$	—	$	1.7
Offsetting of derivative liabilities
		At December 31, 2016									At September 30, 2016
Description	Balance Sheet location	Gross amounts of recognized liabilities			Gross amounts offset in the Balance Sheet			Net amounts of liabilities presented in the Balance Sheet			Gross amounts of recognized liabilities			Gross amounts offset in the Balance Sheet		Net amounts of liabilities presented in the Balance Sheet
Foreign currency contracts	Other current liabilities, Other liabilities	$	(0.9	)	$	—		$	(0.9	)	$	(6.2	)	$	0.2	$	(6.0	)

Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis

The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy:

	December 31, 2016			September 30, 2016
Assets (Liabilities) at estimated fair value:
Deferred compensation	$	(84.3	)	$	(84.5	)
Derivatives - foreign currency contracts	10.5			(5.6		)
Net liabilities at estimated fair value	$	(73.8	)	$	(90.1	)

XML

Segment Data (Tables)

3 Months Ended

Dec. 31, 2016

Segments [Abstract]

Schedule of Segment Sales and Profitability

Segment net sales and profitability are presented below:

	Three Months Ended December 31,
	2016			2015
Net Sales
Wet Shave	$	306.2		$	316.3
Sun and Skin Care	57.6			53.5
Feminine Care	89.1			92.5
All Other	32.1			32.8
Total net sales	$	485.0		$	495.1
Segment Profit
Wet Shave	$	72.0		$	66.8
Sun and Skin Care	0.8			1.7
Feminine Care	8.3			17.6
All Other	6.9			7.2
Total segment profit	88.0			93.3
General corporate and other expenses	(16.4		)	(17.7		)
Spin costs (1)	—			(7.5		)
Restructuring and related costs (2)	(7.2		)	(18.5		)
Amortization of intangibles	(4.0		)	(3.6		)
Interest and other expense, net	(15.5		)	(15.3		)
Total earnings before income taxes	$	44.9		$	30.7

(1) Includes pre-tax Selling, general and administrative expense of $7.3 and pre-tax Cost of products sold of $0.2 for the three months ended December 31, 2015 related to the separation of the Household Products business in July 2015.

(2) Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the three months ended December 31, 2016.

Schedule of Supplemental Product Information

Supplemental product information is presented below for net sales:

	Three Months Ended December 31,
	2016		2015
Razors and blades	$	271.3	$	274.2
Tampons, pads and liners	89.1		92.5
Sun care products	37.7		36.9
Infant care and other	32.1		32.7
Shaving gels and creams	34.9		42.2
Skin care products	19.9		16.6
Total net sales	$	485.0	$	495.1

XML

Guarantor and Non-Guarantor Financial Information (Tables)

3 Months Ended

Dec. 31, 2016

Guarantor and Non-Guarantor Financial Information [Abstract]

Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

Three Months Ended December 31, 2016

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	342.9		$	232.3		$	(90.2	)	$	485.0
Cost of products sold	—			204.5			142.7			(90.2		)	257.0
Gross profit	—			138.4			89.6			—			228.0
Selling, general and administrative expense	—			58.7			35.1			—			93.8
Advertising and sales promotion expense	—			30.2			20.4			—			50.6
Research and development expense	—			16.0			0.3			—			16.3
Restructuring charges	—			2.7			4.2			—			6.9
Interest expense associated with debt	13.4			3.3			0.7			—			17.4
Other expense (income), net	—			0.4			(2.3		)	—			(1.9		)
Intercompany service fees	—			(4.4		)	4.4			—			—
Equity in earnings of subsidiaries	(41.9		)	(21.1		)	—			63.0			—
Earnings before income taxes	28.5			52.6			26.8			(63.0		)	44.9
Income tax (benefit) provision	(5.0		)	10.9			5.5			—			11.4
Net earnings	$	33.5		$	41.7		$	21.3		$	(63.0	)	$	33.5
Statement of Comprehensive Income:
Net earnings	$	33.5		$	41.7		$	21.3		$	(63.0	)	$	33.5
Other comprehensive loss, net of tax	(26.9		)	(3.2		)	(27.8		)	31.0			(26.9		)
Total comprehensive income	$	6.6		$	38.5		$	(6.5	)	$	(32.0	)	$	6.6

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

Three Months Ended December 31, 2015

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net sales	$	—		$	336.8		$	269.5		$	(111.2	)	$	495.1
Cost of products sold	—			204.9			174.8			(112.1		)	267.6
Gross profit	—			131.9			94.7			0.9			227.5
Selling, general and administrative expense	3.1			60.7			36.6			—			100.4
Advertising and sales promotion expense	—			27.5			19.2			(0.1		)	46.6
Research and development expense	—			15.6			0.4			—			16.0
Restructuring charges	—			4.7			13.8			—			18.5
Interest expense associated with debt	16.2			—			1.5			—			17.7
Other income, net	—			(2.4		)	—			—			(2.4		)
Intercompany service fees	—			(5.5		)	5.5			—			—
Equity in earnings of subsidiaries	(35.8		)	(12.4		)	—			48.2			—
Earnings before income taxes	16.5			43.7			17.7			(47.2		)	30.7
Income tax (benefit) provision	(7.2		)	10.0			3.2			1.0			7.0
Net earnings	$	23.7		$	33.7		$	14.5		$	(48.2	)	$	23.7
Statement of Comprehensive Income:
Net earnings	23.7			33.7			14.5			(48.2		)	23.7
Other comprehensive loss, net of tax	(11.9		)	(1.9		)	(11.5		)	13.4			(11.9		)
Total comprehensive income	$	11.8		$	31.8		$	3.0		$	(34.8	)	$	11.8

Schedule of Condensed Consolidating Balance Sheets

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING BALANCE SHEETS

December 31, 2016

	Parent Company		Guarantors		Non-Guarantors		Eliminations			Total
Assets
Current assets
Cash and cash equivalents	$	—	$	5.1	$	413.4	$	—		$	418.5
Trade receivables, net	—		102.2		126.2		—			228.4
Inventories	—		210.8		128.2		—			339.0
Other current assets	—		41.8		109.9		—			151.7
Total current assets	—		359.9		777.7		—			1,137.6
Investment in subsidiaries	3,500.2		841.9		—		(4,342.1		)	—
Intercompany receivables, net (1)	—		579.0		42.7		(621.7		)	—
Intercompany notes receivable (1)	—		1.9		—		(1.9		)	—
Property, plant and equipment, net	—		341.8		130.8		—			472.6
Goodwill	—		1,061.9		367.2		—			1,429.1
Other intangible assets, net	—		1,231.5		157.0		—			1,388.5
Other assets	1.8		0.2		25.4		—			27.4
Total assets	$	3,502.0	$	4,418.1	$	1,500.8	$	(4,965.7	)	$	4,455.2
Liabilities and Shareholders' Equity
Current liabilities	$	7.8	$	236.3	$	229.2	$	—		$	473.3
Intercompany payables, net (1)	621.7		—		—		(621.7		)	—
Intercompany notes payable (1)	—		—		1.9		(1.9		)	—
Long-term debt	1,094.5		586.0		—		—			1,680.5
Deferred income tax liabilities	—		229.7		26.1		—			255.8
Other liabilities	—		231.6		36.0		—			267.6
Total liabilities	1,724.0		1,283.6		293.2		(623.6		)	2,677.2
Total shareholders' equity	1,778.0		3,134.5		1,207.6		(4,342.1		)	1,778.0
Total liabilities and shareholders' equity	$	3,502.0	$	4,418.1	$	1,500.8	$	(4,965.7	)	$	4,455.2

(1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING BALANCE SHEETS

September 30, 2016

	Parent Company		Guarantors		Non-Guarantors		Eliminations			Total
Assets
Current assets
Cash and cash equivalents	$	—	$	5.8	$	733.1	$	—		$	738.9
Trade receivables, net	—		108.9		151.8		—			260.7
Inventories	—		187.7		121.5		—			309.2
Other current assets	—		43.7		99.5		—			143.2
Total current assets	—		346.1		1,105.9		—			1,452.0
Investment in subsidiaries	3,483.7		825.0		—		(4,308.7		)	—
Intercompany receivables, net (1)	—		487.6		53.5		(541.1		)	—
Intercompany notes receivable (1)	—		1.9		—		(1.9		)	—
Property, plant and equipment, net	—		343.8		142.3		—			486.1
Goodwill	—		1,061.9		358.4		—			1,420.3
Other intangible assets, net	—		1,235.1		150.0		—			1,385.1
Other assets	2.0		0.1		25.9		—			28.0
Total assets	$	3,485.7	$	4,301.5	$	1,836.0	$	(4,851.7	)	$	4,771.5
Liabilities and Shareholders' Equity
Current liabilities	$	21.4	$	288.4	$	558.4	$	—		$	868.2
Intercompany payables, net (1)	541.1		—		—		(541.1		)	—
Intercompany notes payable (1)	—		—		1.9		(1.9		)	—
Long-term debt	1,094.2		450.0		—		—			1,544.2
Deferred income tax liabilities	—		232.4		22.9		—			255.3
Other liabilities	—		236.3		38.5		—			274.8
Total liabilities	1,656.7		1,207.1		621.7		(543.0		)	2,942.5
Total shareholders' equity	1,829.0		3,094.4		1,214.3		(4,308.7		)	1,829.0
Total liabilities and shareholders' equity	$	3,485.7	$	4,301.5	$	1,836.0	$	(4,851.7	)	$	4,771.5

(1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

Schedule of Condensed Consolidating Statements of Cash Flows

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Three Months Ended December 31, 2016

	Parent Company			Guarantors			Non-Guarantors			Eliminations		Total
Net cash flow from (used by) operations	$	58.0		$	(124.8	)	$	7.8		$	—	$	(59.0	)
Cash Flow from Investing Activities
Capital expenditures	—			(11.0		)	(2.7		)	—		(13.7		)
Acquisitions, net of cash acquired	—			—			(34.0		)	—		(34.0		)
Net cash used by investing activities	—			(11.0		)	(36.7		)	—		(47.7		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	—			146.0			—			—		146.0
Cash payments on debt with original maturities greater than 90 days	—			(10.0		)	(277.0		)	—		(287.0		)
Net (decrease) increase in debt with original maturities of 90 days or less	—			(0.9		)	0.5			—		(0.4		)
Common shares purchased	(58.0		)	—			—			—		(58.0		)
Net cash (used by) from financing activities	(58.0		)	135.1			(276.5		)	—		(199.4		)
Effect of exchange rate changes on cash	—			—			(14.3		)	—		(14.3		)
Net decrease in cash and cash equivalents	—			(0.7		)	(319.7		)	—		(320.4		)
Cash and cash equivalents, beginning of period	—			5.8			733.1			—		738.9
Cash and cash equivalents, end of period	$	—		$	5.1		$	413.4		$	—	$	418.5

EDGEWELL PERSONAL CARE COMPANY

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Three Months Ended December 31, 2015

	Parent Company			Guarantors			Non-Guarantors			Eliminations			Total
Net cash flow from (used by) operations	$	78.9		$	(123.7	)	$	(13.9	)	$	—		$	(58.7	)
Cash Flow from Investing Activities
Capital expenditures	—			(13.0		)	(1.5		)	—			(14.5		)
Payment for equity contributions	—			(0.2		)	—			0.2			—
Net cash used by investing activities	—			(13.2		)	(1.5		)	0.2			(14.5		)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	—			345.0			2.8			—			347.8
Cash payments on debt with original maturities greater than 90 days	—			(203.0		)	—			—			(203.0		)
Net (decrease) increase in debt with original maturities of 90 days or less	—			(2.4		)	0.2			—			(2.2		)
Common shares purchased	(78.9		)	—			—			—			(78.9		)
Proceeds for equity contributions	—			—			0.2			(0.2		)	—
Net cash (used by) from financing activities	(78.9		)	139.6			3.2			(0.2		)	63.7
Effect of exchange rate changes on cash	—			—			(8.4		)	—			(8.4		)
Net increase (decrease) in cash and cash equivalents	—			2.7			(20.6		)	—			(17.9		)
Cash and cash equivalents, beginning of period	—			2.9			709.2			—			712.1
Cash and cash equivalents, end of period	$	—		$	5.6		$	688.6		$	—		$	694.2

XML

Background and Basis of Presentation (Details) $ in Millions	3 Months Ended
	Dec. 31, 2015 USD ($)	Dec. 31, 2016 brands country
Background and Basis of Presentation [Abstract]
Number of brands | brands		25
Number of countries in which Edgewell operates | country		50
Cash Payments on Debt
Quantifying Misstatement in Current Year Financial Statements [Line Items]
Amount of misstatement | $	$ 203.0

XML

Acquisition (Details) £ in Millions, $ in Millions	Oct. 31, 2016 USD ($)	Oct. 31, 2016 GBP (£)	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)
Business Acquisition [Line Items]
Goodwill			$ 1,429.1	$ 1,420.3
Weighted-average useful life of acquired finite-lived intangible assets	13 years 6 months	13 years 6 months
Bulldog
Business Acquisition [Line Items]
Purchase price, net of cash acquired	$ 34.0	£ 27.8
Net assets acquired	35.2
Working capital and other net assets	4.6
Cash	1.2
Other intangible assets	12.8
Goodwill	$ 17.8

XML

Restructuring Charges (Narrative) (Details) - USD ($) $ in Millions		3 Months Ended		50 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Sep. 30, 2016	Sep. 30, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs	[1]	$ 7.2	$ 18.5
Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		15.9		$ 15.9	$ 16.7	$ 13.7
Restructuring charges incurred to date				147.0
Minimum | Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges expected, fiscal 2017		20.0		20.0
Maximum | Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges expected, fiscal 2017		25.0		25.0
Spinoff | New Energizer | Spin Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		2.7		$ 2.7	$ 5.2
Obsolescence | Cost of products sold | Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs		$ 0.3	$ 0.0

[1] Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the three months ended December 31, 2016.

XML

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 6.9	$ 18.5
Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	6.9	18.5
Restructuring Plan | Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.9	13.6
Restructuring Plan | Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.7	0.7
Restructuring Plan | Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3.3	4.2
Restructuring Plan | Wet Shave
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2.1	11.2
Restructuring Plan | Wet Shave | Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.4	10.5
Restructuring Plan | Wet Shave | Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.0	0.0
Restructuring Plan | Wet Shave | Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.7	0.7
Restructuring Plan | Feminine Care
Restructuring Cost and Reserve [Line Items]
Restructuring charges	4.8	7.3
Restructuring Plan | Feminine Care | Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.5	3.1
Restructuring Plan | Feminine Care | Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.7	0.7
Restructuring Plan | Feminine Care | Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 1.6	$ 3.5

XML

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - Restructuring Plan - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016		Dec. 31, 2015
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 16.7		$ 13.7
Charge to Income	6.9		37.0
Other	(0.7)	[1]	0.6	[2]
Utilized - Cash Payments	(5.3)		(30.7)
Utilized - Non-Cash	(1.7)		(3.9)
Ending Balance	15.9
Severance and termination related costs
Restructuring Reserve [Roll Forward]
Beginning Balance	16.7		13.7
Charge to Income	1.9		17.0
Other	(0.7)	[1]	0.6	[2]
Utilized - Cash Payments	(2.0)		(14.6)
Utilized - Non-Cash	0.0		0.0
Ending Balance	15.9
Asset impairment and accelerated depreciation
Restructuring Reserve [Roll Forward]
Beginning Balance	0.0		0.0
Charge to Income	1.7		3.9
Other	0.0	[1]	0.0	[2]
Utilized - Cash Payments	0.0		0.0
Utilized - Non-Cash	(1.7)		(3.9)
Ending Balance	0.0
Other related costs
Restructuring Reserve [Roll Forward]
Beginning Balance	0.0		0.0
Charge to Income	3.3		16.1
Other	0.0	[1]	0.0	[2]
Utilized - Cash Payments	(3.3)		(16.1)
Utilized - Non-Cash	0.0		$ 0.0
Ending Balance	$ 0.0

[1] Includes the impact of currency translation.

[2] Includes the impact of currency translation.

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Taxes [Abstract]
Income tax provision	$ 11.4	$ 7.0
Earnings before income taxes	$ 44.9	$ 30.7
Effective tax rate	25.40%	22.80%
Impact of favorable tax adjustments on the effective tax rate	4.00%	4.00%

XML

Earnings per Share (Schedule of Earnings per Share) (Details) - shares shares in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Earnings Per Share [Abstract]
Basic weighted-average shares outstanding (in shares)	57.7	59.7
Effective of dilutive securities, share options (in shares)	0.0	0.0
Effective of dilutive securities, RSEs (in shares)	0.4	0.2
Total dilutive securities (in shares)	0.4	0.2
Diluted weighted-average shares outstanding (in shares)	58.1	59.9

XML

Earnings per Share (Narrative) (Details) - shares shares in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.6	0.4
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)		0.2

XML

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) $ in Millions	3 Months Ended
	Dec. 31, 2016 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,420.3
Cumulative translation adjustment	(9.0)
Ending balance	1,429.1
Wet Shave
Goodwill [Roll Forward]
Beginning balance	965.3
Cumulative translation adjustment	(8.0)
Ending balance	957.3
Sun and Skin Care
Goodwill [Roll Forward]
Beginning balance	178.0
Cumulative translation adjustment	0.0
Ending balance	195.8
Feminine Care
Goodwill [Roll Forward]
Beginning balance	207.4
Cumulative translation adjustment	(1.0)
Ending balance	206.4
All Other
Goodwill [Roll Forward]
Beginning balance	69.6
Cumulative translation adjustment	0.0
Ending balance	69.6
Bulldog
Goodwill [Roll Forward]
Acquisition of Bulldog	17.8
Bulldog | Wet Shave
Goodwill [Roll Forward]
Acquisition of Bulldog	0.0
Bulldog | Sun and Skin Care
Goodwill [Roll Forward]
Acquisition of Bulldog	17.8
Bulldog | Feminine Care
Goodwill [Roll Forward]
Acquisition of Bulldog	0.0
Bulldog | All Other
Goodwill [Roll Forward]
Acquisition of Bulldog	$ 0.0

XML

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 266.3		$ 233.3
Amortizable intangible assets, accumulated amortization	164.0		161.6
Amortizable intangible assets, net	102.3		71.7
Amortization of intangibles	4.0	$ 3.6
Amortizable intangible assets, amortization expense, remainder of 2017	12.0
Amortizable intangible assets, amortization expense, fiscal 2018	8.5
Amortizable intangible assets, amortization expense, fiscal 2019	7.3
Amortizable intangible assets, amortization expense, fiscal 2020	6.6
Amortizable intangible assets, amortization expense, fiscal 2021	6.0
Amortizable intangible assets, amortization expense, fiscal 2022	5.9
Amortizable intangible assets, amortization expense, thereafter	56.0
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	45.4		14.6
Amortizable intangible assets, accumulated amortization	12.5		12.2
Amortizable intangible assets, net	32.9		2.4
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	77.0		76.9
Amortizable intangible assets, accumulated amortization	70.3		69.8
Amortizable intangible assets, net	6.7		7.1
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	143.9		141.8
Amortizable intangible assets, accumulated amortization	81.2		79.6
Amortizable intangible assets, net	62.7		$ 62.2
Skintimate brand name
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 0.4
Useful life assigned to Skintimate brand name	20 years
Bulldog
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets acquired during period	$ 4.4

XML

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Sep. 30, 2015
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 1,286.2
Indefinite-lived intangible assets, decrease	(27.2)
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	223.0
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	499.8
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	299.9
All Other
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	263.5
Skintimate brand name
Indefinite-lived Intangible Assets [Line Items]
Impairment charge		$ 6.5	$ 29.6
Skintimate brand name | Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, decrease due to Skintimate conversion to amortizable intangible asset	(30.9)
Bulldog | Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets acquired during the period	$ 8.4

XML

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2016	Sep. 30, 2016
Inventories
Raw materials and supplies	$ 54.0	$ 50.8
Work in process	50.3	43.9
Finished products	234.7	214.5
Inventories	339.0	309.2
Other Current Assets
Miscellaneous receivables	40.9	29.1
Prepaid expenses	53.2	49.0
Value added tax collectible from customers	23.9	22.4
Income taxes receivable	25.2	39.3
Other	8.5	3.4
Other current assets	151.7	143.2
Property, Plant and Equipment
Land	27.2	27.8
Buildings	141.6	146.0
Machinery and equipment	904.7	913.7
Capitalized software costs	38.0	38.4
Construction in progress	43.2	36.2
Total gross property	1,154.7	1,162.1
Accumulated depreciation	(682.1)	(676.0)
Property, plant and equipment, net	472.6	486.1
Other Current Liabilities
Accrued advertising, sales promotion and allowances	44.3	46.8
Accrued trade allowances	24.4	30.1
Accrued salaries, vacations and incentive compensation	26.4	56.0
Income taxes payable	11.9	19.7
Returns reserve	27.4	49.9
Restructuring reserve	18.6	21.9
Value added tax payable	25.6	25.0
Deferred compensation	26.7	26.1
Other	68.1	95.9
Other current liabilities	273.4	371.4
Other Liabilities
Pensions and other retirement benefits	150.0	154.9
Deferred compensation	57.8	58.6
Other non-current liabilities	59.8	61.3
Other liabilities	$ 267.6	$ 274.8

XML

Debt (Details) € in Millions, $ in Millions		Oct. 20, 2016 USD ($)	Oct. 20, 2016 EUR (€)	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)
Debt Instrument [Line Items]
Total long-term debt, including current maturities				$ 1,680.5	$ 1,826.0
Current maturities of long-term debt				0.0	281.8
Long-term debt				1,680.5	1,544.2
Notes payable				18.3	18.5
Senior notes due 2022
Debt Instrument [Line Items]
Unamortized discount				0.8	0.8
Senior notes | Senior notes due 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]			597.9	597.8
Unamortized debt issuance costs				2.1	2.2
Senior notes | Senior notes due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1],[2]			497.0	496.9
Unamortized debt issuance costs				2.2	2.3
Domestic line of credit | US revolving credit facility
Debt Instrument [Line Items]
Total long-term debt, including current maturities				401.0	265.0
Foreign line of credit | Netherlands revolving credit facility
Debt Instrument [Line Items]
Total long-term debt, including current maturities				0.0	281.8
Debt repayment, revolving credit facility		$ 277.0	€ 251.3
Loans payable | Term loan
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]			184.6	184.5
Unamortized debt issuance costs				$ 0.4	$ 0.5

[1] At December 31, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.1, $2.2 and $0.4, respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2, $2.3 and $0.5, respectively.

[2] At December 31, 2016 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.8

XML

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Pension and Other Postretirement Benefits [Abstract]
Service cost	$ 1.8	$ 1.3
Interest cost	3.8	5.5
Expected return on plan assets	(7.9)	(6.9)
Amortization of unrecognized prior service cost	0.0	0.0
Recognized net actuarial loss	1.5	1.0
Settlement loss recognized	0.3	0.0
Net periodic benefit (credit) cost	(0.5)	$ 0.9
Expected decrease in interest and service cost for fiscal 2017	$ 4.0

XML

Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2016	May 31, 2015
Shareholders' Equity [Abstract]
Shares authorized for repurchase (in shares)		10.0
Repurchase of shares (in shares)	0.8
Repurchase of shares (in usd)	$ 58.0
Remaining shares authorized for repurchase (in shares)	4.7
Shares withheld for taxes on share based compensation (in shares)	0.1
Cash dividends paid related to RSE award vests	$ 0.8

XML

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (197.2)	$ (171.5)
OCI before reclassifications	[1]	(27.9)	(15.0)
Reclassifications to earnings		1.0	3.1
Ending balance		(224.1)	(183.4)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(68.1)	(69.1)
OCI before reclassifications	[1]	(38.7)	(10.5)
Reclassifications to earnings		0.0	0.0
Ending balance		(106.8)	(79.6)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(126.3)	(105.7)
OCI before reclassifications	[1]	2.7	(0.1)
Reclassifications to earnings		1.2	0.6
Ending balance		(122.4)	(105.2)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(2.8)	3.3
OCI before reclassifications	[1]	8.1	(4.4)
Reclassifications to earnings		(0.2)	2.5
Ending balance		$ 5.1	$ 1.4

[1] OCI is defined as other comprehensive income (loss).

XML

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings		$ (1.0)	$ (3.1)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		(0.3)	3.6
Gains and losses on cash flow hedges, foreign exchange contracts, tax		0.1	(1.1)
Gains and losses on cash flow hedges, foreign exchange contracts, after tax		(0.2)	2.5
Amortization of defined benefit pension and postretirement items, prior service cost, before tax	[1]	0.0	0.0
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	[1]	1.5	1.0
Amortization of defined benefit pension and postretirement items, settlement loss recognized, before tax	[1]	0.3	0.0
Amortization of defined benefit pension and postretirement items, before tax		1.8	1.0
Amortization of defined benefit pension and postretirement items, tax		(0.6)	(0.4)
Amortization of defined benefit pension and postretirement items, after tax		1.2	0.6
Reclassifications to earnings		1.0	3.1
Other income, net | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ (0.3)	$ 3.6

[1] These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements

XML

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended
		Dec. 31, 2016 USD ($) contracts	Dec. 31, 2015 USD ($)	Sep. 30, 2016 USD ($)
Derivative [Line Items]
Carrying value of long-term debt		$ 1,680.5		$ 1,826.0
Variable rate
Derivative [Line Items]
Variable rate debt outstanding		585.6
Not designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ 2.8		(1.3)
Open foreign currency contracts | contracts		5
Notional value		$ 84.8
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative	[1],[2]	7.7		(4.3)
Portion of unrealized gain on cash flow hedges in AOCI to be recognized over next twelve months		$ 7.4
Open foreign currency contracts | contracts		72
Notional value		$ 132.0
Other income, net | Not designated as hedge | FX contract
Derivative [Line Items]
Change in estimate fair value of foreign currency contracts	[3]	2.6	$ 0.0
Fixed rate
Derivative [Line Items]
Fair value of long-term debt		1,126.3		1,106.2
Carrying value of long-term debt		1,094.9		1,094.7
Term loan
Derivative [Line Items]
Fair value of long-term debt		$ 185.0		$ 185.0

[1] All derivative assets are presented in Other current assets or Other assets.

[2] All derivative liabilities are presented in Other current liabilities or Other liabilities.

[3] Gain recognized in income was recorded in Other income, net.

XML

Financial Instruments and Risk Management (Schedule of Derivative Instruments Designated as Cash Flow Hedges) (Details) - Designated as hedge - Cash flow hedge - FX contract - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Derivative [Line Items]
Estimated fair value of derivative	[1],[2]	$ 7.7		$ (4.3)
Gain recognized in OCI		11.7	$ 0.8
Other income, net
Derivative [Line Items]
(Loss) gain reclassified from OCI into income	[3],[4]	$ (0.3)	$ 3.6

[1] All derivative assets are presented in Other current assets or Other assets.

[2] All derivative liabilities are presented in Other current liabilities or Other liabilities.

[3] (Loss) gain reclassified to income was recorded in Other income, net.

[4] Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.

XML

Financial Instruments and Risk Management (Schedule of Derivative Instruments Not Designated as Cash Flow Hedges) (Details) - Not designated as hedge - FX contract - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Derivative [Line Items]
Estimated fair value of derivative		$ 2.8		$ (1.3)
Other income, net
Derivative [Line Items]
Gain recognized in income	[1]	$ 2.6	$ 0.0

[1] Gain recognized in income was recorded in Other income, net.

XML

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions	Dec. 31, 2016	Sep. 30, 2016
Other current assets
Derivative [Line Items]
Gross amounts of recognized assets	$ 11.9	$ 1.7
Gross amounts of recognized assets offset in the Balance Sheet	(0.5)	0.0
Net amounts of assets presented in the Balance Sheet	11.4	1.7
Other current liabilities
Derivative [Line Items]
Gross amounts of recognized liabilities	(0.9)	(6.2)
Gross amounts of recognized liabilities offset in the Balance Sheet	0.0	0.2
Net amounts of liabilities presented in the Balance Sheet	$ (0.9)	$ (6.0)

XML

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Dec. 31, 2016	Sep. 30, 2016
Derivative [Line Items]
Deferred compensation	$ (84.3)	$ (84.5)
Net liabilities at estimated fair value	(73.8)	(90.1)
FX contract
Derivative [Line Items]
Derivatives - foreign currency contracts	$ 10.5	$ (5.6)

XML

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
Net sales		$ 485.0	$ 495.1
Gross profit		228.0	227.5
Spin costs	[1]	0.0	7.5
Restructuring and related costs	[2]	7.2	18.5
Amortization of intangibles		4.0	3.6
Interest and other expense, net		15.5	15.3
Earnings before income taxes		44.9	30.7
Wet Shave
Segment Reporting Information [Line Items]
Net sales		306.2	316.3
Gross profit		72.0	66.8
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales		57.6	53.5
Gross profit		0.8	1.7
Feminine Care
Segment Reporting Information [Line Items]
Net sales		89.1	92.5
Gross profit		8.3	17.6
All Other
Segment Reporting Information [Line Items]
Net sales		32.1	32.8
Gross profit		6.9	7.2
Operating Segments
Segment Reporting Information [Line Items]
Gross profit		88.0	93.3
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses		16.4	17.7
Spinoff | Selling, general and administrative expense | New Energizer
Segment Reporting Information [Line Items]
Spin costs			7.3
Spinoff | Cost of products sold | New Energizer
Segment Reporting Information [Line Items]
Spin costs			0.2
Obsolescence | Restructuring Plan | Cost of products sold
Segment Reporting Information [Line Items]
Restructuring and related costs		$ 0.3	$ 0.0

[1] Includes pre-tax Selling, general and administrative expense of $7.3 and pre-tax Cost of products sold of $0.2 for the three months ended December 31, 2015 related to the separation of the Household Products business in July 2015.

[2] Includes pre-tax Cost of products sold of $0.3 associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring for the three months ended December 31, 2016.

XML

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenue from External Customer [Line Items]
Net sales	$ 485.0	$ 495.1
Razors and blades
Revenue from External Customer [Line Items]
Net sales	271.3	274.2
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	89.1	92.5
Sun care products
Revenue from External Customer [Line Items]
Net sales	37.7	36.9
Infant care and other
Revenue from External Customer [Line Items]
Net sales	32.1	32.7
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	34.9	42.2
Skin care products
Revenue from External Customer [Line Items]
Net sales	$ 19.9	$ 16.6

XML

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Net sales	$ 485.0	$ 495.1
Cost of products sold	257.0	267.6
Gross profit	228.0	227.5
Selling, general and administrative expense	93.8	100.4
Advertising and sales promotion expense	50.6	46.6
Research and development expense	16.3	16.0
Restructuring charges	6.9	18.5
Interest expense associated with debt	17.4	17.7
Other income, net	(1.9)	(2.4)
Intercompany service fees	0.0	0.0
Equity in earnings of subsidiaries	0.0	0.0
Earnings before income taxes	44.9	30.7
Income tax (benefit) provision	11.4	7.0
Net earnings	33.5	23.7
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	33.5	23.7
Other comprehensive loss, net of tax	(26.9)	(11.9)
Total comprehensive income	6.6	11.8
Eliminations
Income Statement [Abstract]
Net sales	(90.2)	(111.2)
Cost of products sold	(90.2)	(112.1)
Gross profit	0.0	0.9
Selling, general and administrative expense	0.0	0.0
Advertising and sales promotion expense	0.0	(0.1)
Research and development expense	0.0	0.0
Restructuring charges	0.0	0.0
Interest expense associated with debt	0.0	0.0
Other income, net	0.0	0.0
Intercompany service fees	0.0	0.0
Equity in earnings of subsidiaries	63.0	48.2
Earnings before income taxes	(63.0)	(47.2)
Income tax (benefit) provision	0.0	1.0
Net earnings	(63.0)	(48.2)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	(63.0)	(48.2)
Other comprehensive loss, net of tax	31.0	13.4
Total comprehensive income	(32.0)	(34.8)
Parent
Income Statement [Abstract]
Net sales	0.0	0.0
Cost of products sold	0.0	0.0
Gross profit	0.0	0.0
Selling, general and administrative expense	0.0	3.1
Advertising and sales promotion expense	0.0	0.0
Research and development expense	0.0	0.0
Restructuring charges	0.0	0.0
Interest expense associated with debt	13.4	16.2
Other income, net	0.0	0.0
Intercompany service fees	0.0	0.0
Equity in earnings of subsidiaries	(41.9)	(35.8)
Earnings before income taxes	28.5	16.5
Income tax (benefit) provision	(5.0)	(7.2)
Net earnings	33.5	23.7
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	33.5	23.7
Other comprehensive loss, net of tax	(26.9)	(11.9)
Total comprehensive income	6.6	11.8
Guarantors
Income Statement [Abstract]
Net sales	342.9	336.8
Cost of products sold	204.5	204.9
Gross profit	138.4	131.9
Selling, general and administrative expense	58.7	60.7
Advertising and sales promotion expense	30.2	27.5
Research and development expense	16.0	15.6
Restructuring charges	2.7	4.7
Interest expense associated with debt	3.3	0.0
Other income, net	0.4	(2.4)
Intercompany service fees	(4.4)	(5.5)
Equity in earnings of subsidiaries	(21.1)	(12.4)
Earnings before income taxes	52.6	43.7
Income tax (benefit) provision	10.9	10.0
Net earnings	41.7	33.7
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	41.7	33.7
Other comprehensive loss, net of tax	(3.2)	(1.9)
Total comprehensive income	38.5	31.8
Non-Guarantors
Income Statement [Abstract]
Net sales	232.3	269.5
Cost of products sold	142.7	174.8
Gross profit	89.6	94.7
Selling, general and administrative expense	35.1	36.6
Advertising and sales promotion expense	20.4	19.2
Research and development expense	0.3	0.4
Restructuring charges	4.2	13.8
Interest expense associated with debt	0.7	1.5
Other income, net	(2.3)	0.0
Intercompany service fees	4.4	5.5
Equity in earnings of subsidiaries	0.0	0.0
Earnings before income taxes	26.8	17.7
Income tax (benefit) provision	5.5	3.2
Net earnings	21.3	14.5
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	21.3	14.5
Other comprehensive loss, net of tax	(27.8)	(11.5)
Total comprehensive income	$ (6.5)	$ 3.0

XML

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Dec. 31, 2016		Sep. 30, 2016		Dec. 31, 2015	Sep. 30, 2015
Current assets
Cash and cash equivalents	$ 418.5		$ 738.9		$ 694.2	$ 712.1
Trade receivables, net	228.4		260.7
Inventories	339.0		309.2
Other current assets	151.7		143.2
Total current assets	1,137.6		1,452.0
Investment in subsidiaries	0.0		0.0
Intercompany receivables, net	0.0	[1]	0.0	[2]
Intercompany notes receivable	0.0	[1]	0.0	[2]
Property, plant and equipment, net	472.6		486.1
Goodwill	1,429.1		1,420.3
Other intangible assets, net	1,388.5		1,385.1
Other assets	27.4		28.0
Total assets	4,455.2		4,771.5
Liabilities [Abstract]
Current liabilities	473.3		868.2
Intercompany payables, net	0.0	[1]	0.0	[2]
Intercompany notes payable	0.0	[1]	0.0	[2]
Long-term debt	1,680.5		1,544.2
Deferred income tax liabilities	255.8		255.3
Other liabilities	267.6		274.8
Total liabilities	2,677.2		2,942.5
Shareholders' equity
Total shareholders' equity	1,778.0		1,829.0
Total liabilities and shareholders' equity	4,455.2		4,771.5
Eliminations
Current assets
Cash and cash equivalents	0.0		0.0		0.0	0.0
Trade receivables, net	0.0		0.0
Inventories	0.0		0.0
Other current assets	0.0		0.0
Total current assets	0.0		0.0
Investment in subsidiaries	(4,342.1)		(4,308.7)
Intercompany receivables, net	(621.7)	[1]	(541.1)	[2]
Intercompany notes receivable	(1.9)	[1]	(1.9)	[2]
Property, plant and equipment, net	0.0		0.0
Goodwill	0.0		0.0
Other intangible assets, net	0.0		0.0
Other assets	0.0		0.0
Total assets	(4,965.7)		(4,851.7)
Liabilities [Abstract]
Current liabilities	0.0		0.0
Intercompany payables, net	(621.7)	[1]	(541.1)	[2]
Intercompany notes payable	(1.9)	[1]	(1.9)	[2]
Long-term debt	0.0		0.0
Deferred income tax liabilities	0.0		0.0
Other liabilities	0.0		0.0
Total liabilities	(623.6)		(543.0)
Shareholders' equity
Total shareholders' equity	(4,342.1)		(4,308.7)
Total liabilities and shareholders' equity	(4,965.7)		(4,851.7)
Parent
Current assets
Cash and cash equivalents	0.0		0.0		0.0	0.0
Trade receivables, net	0.0		0.0
Inventories	0.0		0.0
Other current assets	0.0		0.0
Total current assets	0.0		0.0
Investment in subsidiaries	3,500.2		3,483.7
Intercompany receivables, net	0.0	[1]	0.0	[2]
Intercompany notes receivable	0.0	[1]	0.0	[2]
Property, plant and equipment, net	0.0		0.0
Goodwill	0.0		0.0
Other intangible assets, net	0.0		0.0
Other assets	1.8		2.0
Total assets	3,502.0		3,485.7
Liabilities [Abstract]
Current liabilities	7.8		21.4
Intercompany payables, net	621.7	[1]	541.1	[2]
Intercompany notes payable	0.0	[1]	0.0	[2]
Long-term debt	1,094.5		1,094.2
Deferred income tax liabilities	0.0		0.0
Other liabilities	0.0		0.0
Total liabilities	1,724.0		1,656.7
Shareholders' equity
Total shareholders' equity	1,778.0		1,829.0
Total liabilities and shareholders' equity	3,502.0		3,485.7
Guarantors
Current assets
Cash and cash equivalents	5.1		5.8		5.6	2.9
Trade receivables, net	102.2		108.9
Inventories	210.8		187.7
Other current assets	41.8		43.7
Total current assets	359.9		346.1
Investment in subsidiaries	841.9		825.0
Intercompany receivables, net	579.0	[1]	487.6	[2]
Intercompany notes receivable	1.9	[1]	1.9	[2]
Property, plant and equipment, net	341.8		343.8
Goodwill	1,061.9		1,061.9
Other intangible assets, net	1,231.5		1,235.1
Other assets	0.2		0.1
Total assets	4,418.1		4,301.5
Liabilities [Abstract]
Current liabilities	236.3		288.4
Intercompany payables, net	0.0	[1]	0.0	[2]
Intercompany notes payable	0.0	[1]	0.0	[2]
Long-term debt	586.0		450.0
Deferred income tax liabilities	229.7		232.4
Other liabilities	231.6		236.3
Total liabilities	1,283.6		1,207.1
Shareholders' equity
Total shareholders' equity	3,134.5		3,094.4
Total liabilities and shareholders' equity	4,418.1		4,301.5
Non-Guarantors
Current assets
Cash and cash equivalents	413.4		733.1		$ 688.6	$ 709.2
Trade receivables, net	126.2		151.8
Inventories	128.2		121.5
Other current assets	109.9		99.5
Total current assets	777.7		1,105.9
Investment in subsidiaries	0.0		0.0
Intercompany receivables, net	42.7	[1]	53.5	[2]
Intercompany notes receivable	0.0	[1]	0.0	[2]
Property, plant and equipment, net	130.8		142.3
Goodwill	367.2		358.4
Other intangible assets, net	157.0		150.0
Other assets	25.4		25.9
Total assets	1,500.8		1,836.0
Liabilities [Abstract]
Current liabilities	229.2		558.4
Intercompany payables, net	0.0	[1]	0.0	[2]
Intercompany notes payable	1.9	[1]	1.9	[2]
Long-term debt	0.0		0.0
Deferred income tax liabilities	26.1		22.9
Other liabilities	36.0		38.5
Total liabilities	293.2		621.7
Shareholders' equity
Total shareholders' equity	1,207.6		1,214.3
Total liabilities and shareholders' equity	$ 1,500.8		$ 1,836.0

[1] Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

[2] Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

XML

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flow from Operating Activities
Net cash flow from (used by) operations	$ (59.0)	$ (58.7)
Cash Flow from Investing Activities
Capital expenditures	(13.7)	(14.5)
Acquisitions, net of cash acquired	(34.0)	0.0
Payment for equity contributions		0.0
Net cash used by investing activities	(47.7)	(14.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	146.0	347.8
Cash payments on debt with original maturities greater than 90 days	(287.0)	(203.0)
Net decrease in debt with original maturities of 90 days or less	(0.4)	(2.2)
Common shares purchased	(58.0)	(78.9)
Proceeds for equity contributions		0.0
Net cash (used by) from financing activities	(199.4)	63.7
Effect of exchange rate changes on cash	(14.3)	(8.4)
Net decrease in cash and cash equivalents	(320.4)	(17.9)
Cash and cash equivalents, beginning of period	738.9	712.1
Cash and cash equivalents, end of period	418.5	694.2
Parent
Cash Flow from Operating Activities
Net cash flow from (used by) operations	58.0	78.9
Cash Flow from Investing Activities
Capital expenditures	0.0	0.0
Acquisitions, net of cash acquired	0.0
Payment for equity contributions		0.0
Net cash used by investing activities	0.0	0.0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0.0	0.0
Cash payments on debt with original maturities greater than 90 days	0.0	0.0
Net decrease in debt with original maturities of 90 days or less	0.0	0.0
Common shares purchased	(58.0)	(78.9)
Proceeds for equity contributions		0.0
Net cash (used by) from financing activities	(58.0)	(78.9)
Effect of exchange rate changes on cash	0.0	0.0
Net decrease in cash and cash equivalents	0.0	0.0
Cash and cash equivalents, beginning of period	0.0	0.0
Cash and cash equivalents, end of period	0.0	0.0
Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	(124.8)	(123.7)
Cash Flow from Investing Activities
Capital expenditures	(11.0)	(13.0)
Acquisitions, net of cash acquired	0.0
Payment for equity contributions		(0.2)
Net cash used by investing activities	(11.0)	(13.2)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	146.0	345.0
Cash payments on debt with original maturities greater than 90 days	(10.0)	(203.0)
Net decrease in debt with original maturities of 90 days or less	(0.9)	(2.4)
Common shares purchased	0.0	0.0
Proceeds for equity contributions		0.0
Net cash (used by) from financing activities	135.1	139.6
Effect of exchange rate changes on cash	0.0	0.0
Net decrease in cash and cash equivalents	(0.7)	2.7
Cash and cash equivalents, beginning of period	5.8	2.9
Cash and cash equivalents, end of period	5.1	5.6
Non-Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	7.8	(13.9)
Cash Flow from Investing Activities
Capital expenditures	(2.7)	(1.5)
Acquisitions, net of cash acquired	(34.0)
Payment for equity contributions		0.0
Net cash used by investing activities	(36.7)	(1.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0.0	2.8
Cash payments on debt with original maturities greater than 90 days	(277.0)	0.0
Net decrease in debt with original maturities of 90 days or less	0.5	0.2
Common shares purchased	0.0	0.0
Proceeds for equity contributions		0.2
Net cash (used by) from financing activities	(276.5)	3.2
Effect of exchange rate changes on cash	(14.3)	(8.4)
Net decrease in cash and cash equivalents	(319.7)	(20.6)
Cash and cash equivalents, beginning of period	733.1	709.2
Cash and cash equivalents, end of period	413.4	688.6
Eliminations
Cash Flow from Operating Activities
Net cash flow from (used by) operations	0.0	0.0
Cash Flow from Investing Activities
Capital expenditures	0.0	0.0
Acquisitions, net of cash acquired	0.0
Payment for equity contributions		0.2
Net cash used by investing activities	0.0	0.2
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0.0	0.0
Cash payments on debt with original maturities greater than 90 days	0.0	0.0
Net decrease in debt with original maturities of 90 days or less	0.0	0.0
Common shares purchased	0.0	0.0
Proceeds for equity contributions		(0.2)
Net cash (used by) from financing activities	0.0	(0.2)
Effect of exchange rate changes on cash	0.0	0.0
Net decrease in cash and cash equivalents	0.0	0.0
Cash and cash equivalents, beginning of period	0.0	0.0
Cash and cash equivalents, end of period	$ 0.0	$ 0.0